<?xml version="1.0" encoding="UTF-8"?>
<svg height="774.244" width="566.9250000000001" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <g begin="text">
   <text y="22.46" x="40.638,48.208,55.778,63.055,66.145,71.865,77.215,81.135,86.765,90.565,95.995,99.085,103.915,109.695,118.435,121.635,126.125,130.955,133.725,139.15,144.87,148.79,151.56,155.19,157.96,162.79,166.59,172.02,177.78,183.56,187.36,191.28,195.77" svgx:width="0.71,0.71,0.71,0.26,0.53,0.49,0.35,0.52,0.34,0.5,0.26,0.44,0.53,0.83,0.28,0.4,0.44,0.23,0.5,0.53,0.35,0.23,0.32,0.23,0.44,0.34,0.5,0.53,0.53,0.34,0.35,0.4,0.28" style="fill:rgb(255,255,255);font-family:Corbel2;font-size:10.0px;stroke:none;">www.nature.com/scientificreports/</text>
  </g>
  <g begin="text">
   <text y="764.23" x="549.491" svgx:width="0.51" style="fill:rgb(131,144,151);font-family:Corbel2;font-size:10.0px;stroke:none;">8</text>
  </g>
  <g begin="text">
   <text y="764.244" x="40.794,45.642,50.786,53.186,58.026,64.026,68.898,71.298,75.762,78.162" svgx:width="0.55,0.59,0.25,0.55,0.7,0.56,0.25,0.5,0.25,0.59" style="fill:rgb(131,144,151);font-family:Corbel2;font-size:8.0px;stroke:none;">SCiEntifiC</text>
   <text y="764.244" x="83.162" svgx:width="0.2" style="fill:rgb(0,0,0);font-family:Corbel2;font-size:8.0px;stroke:none;"> </text>
   <text y="764.244" x="84.762,90.218,95.194,100.434,106.738,112.194,117.186" svgx:width="0.63,0.57,0.6,0.73,0.63,0.57,0.58" style="fill:rgb(131,144,151);font-family:Corbel-Bold2;font-size:8.0px;stroke:none;">REPORTS</text>
   <text y="764.244" x="122.082,123.522,125.338,126.778,130.88" svgx:width="0.2,0.23,0.2,0.51,0.26" style="fill:rgb(0,0,0);font-family:Corbel;font-size:8.0px;stroke:none;"> | 7:</text>
   <text y="764.244" x="132.994,134.45,138.386,142.322,146.258,150.194,154.13" svgx:width="0.18,0.49,0.49,0.49,0.49,0.49,0.18" style="fill:rgb(0,0,0);font-family:MyriadPro-It;font-size:8.0px;stroke:none;"> 10295 </text>
   <text y="764.244" x="155.586,157.027,158.843,160.285,165.653,171.493,173.461,175.573,179.677,183.781,185.893,189.997,194.101,198.205,202.309,204.509,207.741,211.845,215.949,220.053,224.157,228.261,230.925,235.029,239.133,243.237,245.901,250.005,254.109,258.213,262.317,266.421,269.085" svgx:width="0.2,0.23,0.2,0.67,0.73,0.25,0.26,0.51,0.51,0.26,0.51,0.51,0.51,0.51,0.28,0.4,0.51,0.51,0.51,0.51,0.51,0.33,0.51,0.51,0.51,0.33,0.51,0.51,0.51,0.51,0.51,0.33,0.51" style="fill:rgb(0,0,0);font-family:Corbel;font-size:8.0px;stroke:none;"> | DOI:10.1038/s41598-017-10737-9</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M40.640 752.550 L554.640 752.550 "/>
  <g begin="text">
   <text y="56.5" x="155.638,161.831,165.784,169.115,171.086,174.488,179.042,181.283,185.406,189.305" svgx:width="0.69,0.44,0.37,0.23,0.37,0.51,0.25,0.46,0.43,0.53" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">was solved</text>
   <text y="53.44" x="194.086,196.912" svgx:width="0.48,0.48" style="fill:rgb(0,0,255);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">16</text>
   <text y="56.5" x="199.739,201.818,203.789,211.835,216.182,218.153,220.567,223.897,225.868,229.892,232.169,235.573,240.19,242.161,246.797,250.047,253.946,258.725,261.164,265.062,267.782,271.68,276.458,278.43,281.148,285.765,287.736,290.175,294.955,297.674,301.526,304.892,308.87,312.768,315.54,317.511,322.148,325.569,328.008,335.38,339.279,342.699,345.184,347.426,351.584,353.555,359.775,362.107,364.934,369.767,371.736,378.109,383.842,389.926,396.21,398.289,400.26,406.516,411.349,413.788,417.57,422.403,424.374,426.678,429.117,432.969,436.299,438.27,442.78,447.73,449.701,452.527,457.326,461.178,463.149,467.047,471.828,474.646,477.05,481.731,486.43,491.147,495.305,497.276,500.562,505.368,508.789,511.48,515.458,519.292,523.144,525.115,530.03,533.937,537.836,541.202,543.173,546.0,550.798,554.623" svgx:width="0.23,0.23,0.89,0.48,0.23,0.27,0.37,0.23,0.44,0.25,0.37,0.51,0.23,0.52,0.37,0.43,0.53,0.27,0.42,0.31,0.43,0.53,0.23,0.31,0.51,0.23,0.27,0.55,0.31,0.43,0.37,0.44,0.42,0.31,0.23,0.52,0.37,0.27,0.82,0.44,0.37,0.27,0.25,0.46,0.23,0.69,0.27,0.31,0.53,0.23,0.74,0.63,0.67,0.74,0.23,0.23,0.69,0.53,0.27,0.42,0.53,0.23,0.25,0.27,0.43,0.37,0.23,0.51,0.55,0.23,0.31,0.53,0.43,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.37,0.53,0.37,0.3,0.44,0.42,0.43,0.23,0.55,0.43,0.44,0.37,0.23,0.31,0.53,0.43,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">. M2 is also predicted to interact primarily with DYKD, which lies on the antibody surface near the </text>
   <text y="66.499" x="155.639,160.368,164.206,167.954,172.187,176.273,179.432,181.664,184.031,188.265,192.858,195.558,197.25,200.962,205.7,209.529,211.896,216.774,218.466,220.833,225.544,228.194,231.974,235.326,237.945,241.851,245.613,249.343,251.35,253.042,262.605,266.385,268.077,270.249,274.335,277.593,279.96,284.807,288.587,290.279,296.43,298.693,301.451,306.212,308.579,313.457,315.149,321.642,327.654,333.315,339.885,341.577,343.921,347.179,348.871,353.437,356.618,360.446,365.153,367.52,371.349,374.0,377.828,382.535,384.227,386.878,391.423,393.115,395.657,400.098,403.449,410.775,412.467,416.373,418.065,421.382,425.336,427.464,430.164,431.856,436.279,439.63,441.997,446.704,450.803,454.583,456.275,462.425,464.688,467.447,472.208,473.9,477.806,479.497,483.731,485.859,490.489,493.247,497.075,504.401,506.768,510.53,512.222,516.128,519.89,522.257,526.964,528.656,531.837,535.617,538.875,541.242,545.846,550.58,554.405" svgx:width="0.53,0.43,0.44,0.46,0.46,0.36,0.25,0.27,0.47,0.53,0.31,0.23,0.42,0.53,0.44,0.27,0.55,0.23,0.27,0.55,0.31,0.43,0.37,0.3,0.44,0.42,0.43,0.23,0.23,1.07,0.43,0.23,0.25,0.46,0.37,0.27,0.55,0.43,0.23,0.69,0.27,0.31,0.53,0.27,0.55,0.23,0.74,0.67,0.63,0.74,0.23,0.27,0.37,0.23,0.52,0.37,0.43,0.53,0.27,0.42,0.31,0.43,0.53,0.23,0.31,0.51,0.23,0.3,0.51,0.37,0.82,0.23,0.44,0.23,0.37,0.44,0.25,0.31,0.23,0.51,0.37,0.27,0.53,0.47,0.43,0.23,0.69,0.27,0.31,0.53,0.23,0.44,0.23,0.47,0.25,0.53,0.31,0.44,0.82,0.27,0.42,0.23,0.44,0.42,0.27,0.53,0.23,0.37,0.43,0.37,0.27,0.53,0.53,0.43,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">heavy-light chain interface. The lysine within DKYD is predicted to form a salt bridge with a glutamic acid residue </text>
   <text y="76.498" x="155.639,159.401,162.128,163.847,166.628,171.379,175.186,176.905,181.503,185.409,188.766,192.573,194.292,198.756,201.402,203.121,206.972,211.877,213.596,217.529,221.318,223.712,228.446,230.84,234.629,236.348,241.1,245.609,247.912,250.171,254.599,261.024,263.058,264.777,268.71,273.336,275.649,279.582,283.371,287.178,291.912,294.639,296.358,299.031,303.603,305.322,308.102,312.89,315.257,318.542,320.261,324.113,327.317,331.124,332.843,335.597,341.671,346.243,347.962,351.751,356.215,361.048,364.404,368.211,371.792,375.869,379.72,384.454,386.173,388.926,393.066,396.27,400.842,404.127,406.521,411.39,415.197,418.482,420.201,422.982,427.742,431.504,434.231,435.95,443.275,447.046,451.159,452.878,455.442,459.906,463.281,470.634" svgx:width="0.44,0.31,0.23,0.31,0.53,0.43,0.23,0.51,0.44,0.37,0.43,0.23,0.51,0.3,0.23,0.44,0.55,0.23,0.44,0.42,0.27,0.53,0.27,0.42,0.23,0.53,0.51,0.25,0.25,0.51,0.69,0.23,0.23,0.44,0.53,0.26,0.44,0.42,0.43,0.55,0.31,0.23,0.31,0.51,0.23,0.31,0.53,0.27,0.37,0.23,0.44,0.37,0.43,0.23,0.31,0.69,0.51,0.23,0.42,0.51,0.55,0.37,0.43,0.37,0.46,0.43,0.53,0.23,0.31,0.46,0.37,0.51,0.37,0.27,0.55,0.43,0.37,0.23,0.31,0.53,0.44,0.31,0.23,0.82,0.44,0.46,0.23,0.3,0.51,0.37,0.82,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">at the base of an acidic hollow; adjacent to this are two conserved tyrosines that may form </text>
   <text y="76.498" x="472.353" svgx:width="0.6" style="fill:rgb(0,0,0);font-family:EuclidSymbol;font-size:9.0px;stroke:none;">π</text>
   <text y="76.498" x="477.668,480.854,484.093,486.874,490.807,494.542,499.023,501.417,506.25,510.444,512.163,514.557,519.29,521.963,525.77,529.091,533.024,536.875,539.647,542.041,546.505,551.337,554.64" svgx:width="0.36,0.37,0.31,0.44,0.42,0.5,0.27,0.55,0.47,0.23,0.27,0.55,0.31,0.43,0.37,0.44,0.42,0.31,0.27,0.51,0.55,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">-stacking interactions </text>
   <text y="86.497" x="155.639,161.831,164.135,166.934,171.74,173.54,176.339,181.109,184.934,186.734,189.506,193.664,196.886,201.476,204.779,207.191,212.077,215.902,217.702,220.114,225.037,226.837,233.181,238.887,244.944,251.199,253.251,255.051,259.191,263.97,267.363,270.585,275.076,279.855,284.742,289.494,291.906,296.757,300.969,302.769,305.568,310.338,314.163,315.963,318.735,322.892,326.114,330.704,334.007,336.419,341.306,345.131,348.434,350.234,354.104,357.326,361.151,362.951,365.723,371.816,376.406,378.206,381.959,384.128,388.88,392.138,394.829,398.654,401.939,405.242,407.042,411.524,414.188,415.988,420.784,425.374,428.677,430.981,433.771,436.12,440.215,444.004,446.218,450.349,452.149,455.902,460.681,464.551,467.818,471.958,475.828,480.58,482.38,485.602,489.427,492.73,495.142,499.786,504.565,508.39,511.693,513.745,515.545,521.773,526.579,528.991,532.744,537.55,539.35,546.694,550.483,554.614" svgx:width="0.69,0.27,0.31,0.53,0.23,0.31,0.53,0.43,0.23,0.31,0.46,0.37,0.51,0.37,0.27,0.55,0.43,0.23,0.27,0.55,0.23,0.74,0.63,0.67,0.74,0.23,0.23,0.47,0.53,0.37,0.37,0.51,0.53,0.55,0.53,0.27,0.55,0.47,0.23,0.31,0.53,0.43,0.23,0.31,0.46,0.37,0.51,0.37,0.27,0.55,0.43,0.37,0.23,0.44,0.37,0.43,0.23,0.31,0.69,0.51,0.23,0.42,0.25,0.53,0.37,0.31,0.43,0.37,0.37,0.23,0.51,0.3,0.23,0.52,0.51,0.37,0.27,0.31,0.27,0.46,0.43,0.25,0.46,0.23,0.42,0.53,0.44,0.37,0.47,0.43,0.53,0.23,0.37,0.43,0.37,0.27,0.53,0.53,0.43,0.37,0.23,0.23,0.69,0.53,0.27,0.42,0.53,0.23,0.82,0.44,0.46,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">with the tyrosine in DYKD. Surrounding the tyrosines are two clusters of positively charged residues, which may </text>
   <text y="96.496" x="155.639,158.95,161.801,165.733,170.25,172.76,175.091,177.557,181.391,185.27,187.295,190.147,194.969,198.848,200.873,205.813,209.692,213.958,217.791,220.633,223.035,227.183,231.025,233.292,237.477,239.502,243.308,248.14,252.062,255.382,259.575,263.498,268.304,270.329,274.306,277.616,282.43,286.353,289.834,292.677,295.143,299.004,301.029,305.034,308.895,311.361,316.167,318.192,321.467,325.346,328.703,331.169,335.866,340.699,344.578,347.935,350.041,352.066,358.788,363.287,369.432,373.382,377.53,381.409,384.234,386.34,388.365,391.217,396.04,399.919,401.944,405.255,410.088,413.949,417.81,421.689,425.0,428.357,431.127,436.004,438.335,440.36,445.166,449.045,452.402,454.868,459.177,464.081,467.438,469.463,474.286,478.165,481.441,485.32,487.345,491.268,496.207,501.013,503.038,511.111,515.485,517.51,520.83,525.661,529.584,532.859,536.738,538.763,543.298,548.319,550.586,554.717" svgx:width="0.37,0.31,0.44,0.51,0.27,0.25,0.27,0.42,0.43,0.23,0.31,0.53,0.43,0.23,0.55,0.43,0.47,0.44,0.31,0.27,0.46,0.43,0.25,0.46,0.23,0.42,0.53,0.44,0.37,0.47,0.43,0.53,0.23,0.44,0.37,0.52,0.44,0.37,0.31,0.27,0.42,0.23,0.44,0.42,0.27,0.53,0.23,0.37,0.43,0.37,0.27,0.53,0.53,0.43,0.37,0.23,0.23,0.77,0.51,0.69,0.43,0.46,0.43,0.37,0.23,0.23,0.31,0.53,0.43,0.23,0.37,0.53,0.42,0.42,0.43,0.37,0.37,0.3,0.53,0.25,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.37,0.23,0.53,0.43,0.37,0.43,0.23,0.44,0.55,0.53,0.23,0.89,0.48,0.23,0.37,0.53,0.44,0.37,0.43,0.23,0.51,0.55,0.25,0.46,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">stabilize the negatively charged aspartic acid residues. However, the successful designs here and M2 share only </text>
   <text y="106.495" x="155.639,159.509,164.432,166.331,169.778,176.465,182.054,186.815,190.901,194.51,196.409,203.744,208.235,211.025,213.437,216.101,218.0,221.114,224.336,228.161,231.464,233.876,238.52,243.299,247.124,250.427,252.326,256.646,260.966,265.646,269.966,274.286,277.4,279.299,281.711,286.634,288.533,294.518,301.052,306.641,308.54,313.382,317.702,319.754,321.653,327.845,332.732,337.223,340.022,344.792,348.617,351.956,353.855,358.238,362.135,366.266,368.165,372.917,375.329,380.297,384.122,387.344,391.169,396.056,399.863,403.688,405.587,407.972,411.275,413.174,415.973,420.752,424.532,427.277,429.176,437.195,441.515,443.414,447.248,451.118,456.041,457.94,462.404,464.816,469.703,474.455,476.354,479.153,483.923,487.748,489.647,492.365,497.189,499.511,501.788,503.687,508.448,513.371,519.338,525.773,527.672,532.469,536.294,540.91,543.7,546.112,550.864,554.689" svgx:width="0.44,0.55,0.23,0.4,0.74,0.62,0.53,0.47,0.4,0.23,0.82,0.51,0.31,0.27,0.3,0.23,0.35,0.37,0.43,0.37,0.27,0.53,0.53,0.43,0.37,0.23,0.48,0.48,0.52,0.48,0.48,0.35,0.23,0.27,0.55,0.23,0.67,0.74,0.62,0.23,0.54,0.48,0.23,0.23,0.69,0.55,0.51,0.31,0.53,0.43,0.37,0.23,0.5,0.43,0.46,0.23,0.53,0.27,0.56,0.43,0.37,0.43,0.55,0.42,0.43,0.23,0.27,0.37,0.23,0.31,0.53,0.44,0.31,0.23,0.89,0.48,0.23,0.42,0.44,0.55,0.23,0.51,0.27,0.55,0.53,0.23,0.31,0.53,0.43,0.23,0.3,0.53,0.25,0.25,0.23,0.53,0.54,0.69,0.71,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">an “NRFS” motif (residues 53–56) in CDR L2. Another key difference is that M2 can bind the full FLAG peptide </text>
   <text y="116.494" x="155.639,159.419,162.164,164.0,167.87,172.586,176.717,178.553,180.83,185.5,189.334,193.114,195.904,198.316,202.798,207.721,209.557,215.749,218.053,220.851,225.657,228.069,232.992,234.828,238.779,240.615,245.223,248.445,252.936,255.627,259.452,261.864,266.787,268.839,270.675,275.148,279.819,282.564,284.4,289.287,293.778,296.523,298.359,301.158,305.928,309.753,311.589,316.512,319.716,322.407,326.232,329.624,336.995,339.407,344.303,348.299,350.576,352.412,356.219,360.701,363.923,367.748,369.584,374.381,378.206,382.823,385.613,388.025,392.777,396.602,398.441,404.786,410.492,416.549,423.164,425.0,428.222,432.092,435.899,440.489,444.745,449.668,452.08,455.86,459.73,464.482,466.318,470.746,474.877,476.713,479.512,484.282,488.107,489.943,496.711,501.328,504.073,510.058,516.592,522.181,524.017,528.769,532.594,535.897,538.309,542.565,547.416,550.719" svgx:width="0.44,0.31,0.23,0.44,0.55,0.46,0.23,0.25,0.51,0.42,0.44,0.31,0.27,0.51,0.55,0.23,0.69,0.27,0.31,0.53,0.27,0.55,0.23,0.44,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23,0.23,0.51,0.53,0.31,0.23,0.55,0.51,0.31,0.23,0.31,0.53,0.43,0.23,0.55,0.36,0.31,0.43,0.37,0.82,0.27,0.55,0.44,0.25,0.23,0.42,0.51,0.37,0.43,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.23,0.74,0.63,0.67,0.74,0.23,0.37,0.43,0.42,0.51,0.47,0.55,0.27,0.42,0.43,0.53,0.23,0.51,0.46,0.23,0.31,0.53,0.43,0.23,0.75,0.52,0.31,0.67,0.74,0.62,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">at any location within a protein, but not the n-terminal core peptide DYKD recognized by the OptCDR designs.</text>
   <text y="126.493" x="167.636,172.397,174.809,179.705,183.701,186.023,188.237,191.711,193.763,195.635,199.514,203.465,207.218,212.024,213.896,218.378,221.042,222.914,225.713,230.483,234.308,236.18,239.438,244.217,248.024,251.831,255.656,258.913,262.216,264.934,269.758,272.035,273.907,278.659,282.484,285.787,288.199,292.456,297.307,300.61,302.482,304.894,309.646,312.337,316.162,319.501,323.452,327.321,330.066,333.369,335.241,341.432,343.736,346.535,351.341,353.213,356.012,360.782,364.607,366.479,371.276,375.101,379.717,382.507,384.919,389.671,393.496,395.368,397.78,402.703,404.575,408.526,410.398,417.742,421.612,426.535,431.422,435.247,438.586,440.458,443.257,448.036,451.816,454.561,456.433,461.185,465.856,469.681,472.984,474.856,479.743,484.234,486.979,488.851,493.603,495.988,499.291,502.72,507.391,512.008,514.753,516.625,519.424,524.194,528.019,529.891,536.235,541.941,547.998,554.613" svgx:width="0.53,0.27,0.55,0.44,0.25,0.25,0.46,0.23,0.23,0.43,0.44,0.42,0.53,0.23,0.51,0.3,0.23,0.31,0.53,0.43,0.23,0.37,0.53,0.42,0.42,0.43,0.37,0.37,0.3,0.53,0.25,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.37,0.23,0.27,0.55,0.31,0.43,0.37,0.44,0.42,0.31,0.37,0.23,0.69,0.27,0.31,0.53,0.23,0.31,0.53,0.43,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.23,0.27,0.55,0.23,0.44,0.23,0.82,0.44,0.55,0.55,0.43,0.37,0.23,0.31,0.53,0.44,0.31,0.23,0.53,0.51,0.43,0.37,0.23,0.55,0.51,0.31,0.23,0.53,0.27,0.37,0.37,0.53,0.52,0.31,0.23,0.31,0.53,0.43,0.23,0.74,0.63,0.67,0.74,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">Finally, each of the successful designs interacts with the peptide in a manner that does not disrupt the DYKD </text>
   <text y="136.492" x="155.639,160.509,164.406,169.097,171.96,174.444,179.268,183.165,185.262,188.594,191.458,194.96,199.811,203.755,206.483,211.334,214.629,218.526,220.623,225.242,229.886,233.334,237.231,240.905,245.073,249.017,253.841,255.938,258.422,263.417,265.514,270.609,277.217,282.581,284.678,289.07,294.254,298.592,303.697,305.821,307.918,310.916,315.911,318.008,322.843,326.786,330.289,333.152,335.636,339.58,344.477,346.855,350.798,353.644,355.768,357.865,360.737,365.581,369.478,371.575,374.907,377.78,381.731,386.269,388.8,391.149,393.633,397.485,399.969,404.894,409.178,411.275,415.948,420.08,424.904,428.2,432.862,437.076,440.973,445.968,448.065,452.792,457.348,462.308,467.132,469.229,473.955,477.852,480.698,486.865,490.808,494.705,499.7,501.797,504.67,509.513,513.41,515.507,520.378,524.275,528.965,531.829,534.313,539.137,543.034,545.131,550.27,554.59" svgx:width="0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.23,0.37,0.31,0.37,0.53,0.42,0.31,0.53,0.37,0.43,0.23,0.51,0.51,0.37,0.43,0.37,0.46,0.43,0.53,0.23,0.27,0.55,0.23,0.56,0.74,0.59,0.23,0.48,0.57,0.47,0.7,0.23,0.23,0.34,0.55,0.23,0.52,0.44,0.37,0.31,0.27,0.42,0.53,0.25,0.44,0.37,0.23,0.23,0.31,0.53,0.43,0.23,0.37,0.31,0.44,0.51,0.27,0.25,0.27,0.42,0.27,0.55,0.47,0.23,0.53,0.46,0.53,0.37,0.51,0.47,0.43,0.55,0.23,0.51,0.51,0.55,0.53,0.23,0.51,0.43,0.31,0.69,0.43,0.43,0.55,0.23,0.31,0.53,0.43,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.23,0.56,0.48,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">peptide structure observed in PDB 3ESV. In particular, the stabilizing hydrogen bond between the peptide P4 </text>
   <text y="146.491" x="155.639,159.563,162.821,167.582,171.452,174.881,177.671,180.083,183.89,185.645,189.596,193.403,195.815,200.567,202.322,206.192,211.079,215.831,217.586,220.384,225.155,228.98,230.735,234.569,238.439,241.832,245.225,247.637,251.462,254.801,256.556,261.164,264.386,268.877,271.568,275.393,277.805,282.728,284.483,286.868,290.171,291.926,299.27,303.141,305.553,310.304,313.103,316.973,319.385,324.272,328.142,332.894,334.649,338.519,343.406,348.158,349.913,352.712,357.482,361.307,363.062,366.932,371.683,374.473,376.849,381.502,386.173,390.925,393.337,397.162,400.465,402.22,404.632,409.384,412.075,415.9,419.239,423.19,427.06,429.805,431.56,437.751,440.055,442.854,447.66,449.415,454.176,459.099,465.066,471.501,473.256,476.01,479.232,483.714,491.085,492.84,496.791,498.546,503.298,505.71,508.932,512.802,516.671,519.461,521.873,526.355,531.278,533.033,535.832,540.611,544.391,547.136,548.891,551.276,554.579" svgx:width="0.44,0.37,0.52,0.44,0.37,0.31,0.27,0.42,0.23,0.44,0.42,0.27,0.53,0.23,0.44,0.55,0.53,0.23,0.31,0.53,0.43,0.23,0.42,0.44,0.37,0.37,0.27,0.43,0.37,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23,0.27,0.37,0.23,0.82,0.44,0.27,0.55,0.31,0.44,0.27,0.55,0.43,0.53,0.23,0.44,0.55,0.53,0.23,0.31,0.53,0.43,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.27,0.43,0.37,0.23,0.27,0.55,0.31,0.43,0.37,0.44,0.42,0.31,0.23,0.69,0.27,0.31,0.53,0.23,0.53,0.54,0.69,0.71,0.23,0.3,0.37,0.51,0.82,0.23,0.44,0.23,0.53,0.27,0.37,0.43,0.42,0.31,0.27,0.51,0.55,0.23,0.31,0.53,0.44,0.31,0.23,0.27,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">aspartic acid and the carrier protein is maintained and the antibodies interact with FLAG from a direction that is </text>
   <text y="156.49" x="155.639,160.5,164.965,167.683,169.393,173.191,177.412,182.182,186.026,189.87,192.534,196.377,201.102,202.812,205.476,210.039,211.749,215.556,219.31,224.036,227.385,231.183,232.893,235.278,238.645,241.841,245.684,249.464,253.92,258.781,262.561,264.992,267.269,271.122,275.604,277.854,281.652,283.362,286.594,289.259,293.057,296.424,298.809,302.589,304.299,308.025,310.303,314.201,317.442,322.186,325.984,329.26,330.97,337.136,339.414,342.187,346.966,348.676,351.448,356.192,359.99,361.7,365.507,369.351,372.718,376.085,378.47,382.268,385.58,387.29,391.871,395.067,399.533,402.197,405.995,408.38,413.276,415.301,417.011,423.06,426.336,428.046,432.771,435.13,438.478,442.322,447.047,450.279,453.628,457.472,462.197,463.907,466.292,471.188,472.898,475.671,480.415,484.213,485.923,493.232,497.03,499.803,504.546,509.191,513.889,517.165,519.19,520.9,523.673,528.417,532.215,535.564,539.362,541.072,543.629,547.481,551.405" svgx:width="0.55,0.51,0.31,0.23,0.43,0.47,0.52,0.43,0.42,0.31,0.43,0.53,0.23,0.31,0.51,0.23,0.42,0.44,0.53,0.37,0.43,0.23,0.27,0.37,0.37,0.43,0.42,0.51,0.55,0.42,0.27,0.25,0.44,0.51,0.25,0.43,0.23,0.37,0.31,0.43,0.37,0.27,0.42,0.23,0.42,0.25,0.44,0.37,0.53,0.43,0.37,0.23,0.69,0.27,0.31,0.53,0.23,0.31,0.53,0.43,0.23,0.42,0.44,0.37,0.37,0.27,0.43,0.37,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23,0.23,0.69,0.37,0.23,0.53,0.27,0.37,0.42,0.53,0.37,0.37,0.43,0.53,0.23,0.27,0.55,0.23,0.31,0.53,0.43,0.23,0.82,0.43,0.31,0.53,0.51,0.53,0.37,0.23,0.23,0.31,0.53,0.43,0.37,0.43,0.23,0.3,0.43,0.44,0.36" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">not expected to cause irreconcilable steric clashes with the carrier protein. As discussed in the methods, these fea-</text>
   <text y="166.489" x="155.639,158.294,163.073,166.295,170.12,173.423,175.362,181.455,185.28,188.502,192.327,194.267,199.154,203.645,206.39,208.329,212.136,216.618,221.469,224.727,227.517,230.856,234.726,237.138,241.89,244.635,247.938,249.878,254.63,258.005,261.874,266.626,268.57,273.214,277.993,281.385,283.797,288.648,292.86,294.804,297.602,302.372,306.197,308.137,312.889,316.714,320.017,322.429,326.686,331.609,333.548,338.156,341.378,346.049,349.856,353.681,356.939,360.242,362.294,364.234,372.019,376.501,379.723,383.593,388.039,392.134,395.959,398.73,400.782,402.726,408.953,413.759,416.215,418.492,422.317,424.257,428.253,430.575,432.852,434.791,437.374,441.865,446.644,449.983,451.923,456.504,460.383,464.955,468.258,470.197,474.661,477.073,481.96,486.712,488.652,491.91,494.7,497.922,502.404,507.255,511.53,513.744,517.875,519.814,522.226,527.149,529.089,534.201,539.042,542.111,546.377,552.596,554.648" svgx:width="0.31,0.53,0.37,0.43,0.37,0.23,0.69,0.43,0.37,0.43,0.23,0.55,0.51,0.31,0.23,0.42,0.51,0.55,0.37,0.31,0.37,0.44,0.27,0.55,0.31,0.37,0.23,0.53,0.37,0.43,0.53,0.23,0.53,0.53,0.37,0.27,0.55,0.47,0.23,0.31,0.53,0.43,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.23,0.52,0.37,0.51,0.42,0.43,0.37,0.37,0.23,0.23,0.89,0.51,0.37,0.43,0.51,0.46,0.43,0.37,0.23,0.23,0.69,0.53,0.27,0.25,0.43,0.23,0.44,0.25,0.25,0.23,0.3,0.51,0.53,0.37,0.23,0.53,0.44,0.51,0.37,0.23,0.51,0.27,0.55,0.53,0.23,0.37,0.31,0.37,0.51,0.55,0.47,0.25,0.46,0.23,0.27,0.55,0.23,0.57,0.54,0.34,0.47,0.69,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">tures were not constraints used during the design process. Moreover, while all four Fabs bind strongly in ELISA, </text>
   <text y="176.488" x="155.639,160.513,164.982,169.855,173.671,175.394,179.845,182.244,187.118,191.857,193.58,198.323,202.135,207.018,210.785,213.426,218.196,221.405,225.262,230.0,231.724,236.633,239.828,246.16,251.852,257.9,264.502,267.693,271.514,275.37,278.75,282.13,284.529,288.34,291.67,293.393,297.988,301.198,305.675,308.353,312.169,314.567,319.481,321.204,325.673,330.583,332.306,336.248,337.971,345.824,349.636,352.881,355.559,359.375,362.754,367.664,369.387,373.884,376.147,380.625,383.357,385.396,387.119,393.226,397.695,402.398,406.48,410.291,413.564,416.925,420.702,422.902,426.364,428.402,430.126,432.911,437.668,441.48,443.203,446.997,451.466,458.824,466.145,469.961,473.17,476.963,479.39,483.372,485.636,487.359,495.369,499.676,501.399,505.256,509.995,512.772,515.135,519.775,524.432,529.109,533.226,534.95,539.401,541.799,546.673,551.385,554.688" svgx:width="0.55,0.51,0.55,0.43,0.23,0.51,0.27,0.55,0.53,0.23,0.53,0.43,0.55,0.44,0.31,0.53,0.37,0.43,0.53,0.23,0.55,0.36,0.74,0.63,0.67,0.74,0.36,0.42,0.44,0.37,0.37,0.27,0.43,0.37,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23,0.51,0.55,0.23,0.44,0.23,0.97,0.43,0.37,0.31,0.43,0.37,0.55,0.23,0.51,0.25,0.51,0.31,0.23,0.23,0.67,0.51,0.55,0.46,0.43,0.37,0.37,0.43,0.25,0.46,0.23,0.23,0.31,0.53,0.43,0.23,0.42,0.51,0.82,0.82,0.43,0.37,0.42,0.27,0.44,0.25,0.23,0.89,0.48,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.51,0.27,0.55,0.53,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">none bind denatured n-DYKD-carrier protein on a Western blot. Conversely, the commercial M1 antibody binds </text>
   <text y="186.487" x="155.639,158.49,163.312,167.191,169.216,172.626,176.548,183.934,187.813,189.838,194.815,198.073,204.47,210.23,216.341,223.01,225.035,227.366,229.832,234.098,238.02,242.96,247.766,249.786,252.252,257.229,259.254,267.172,271.051,274.362,277.105,280.984,284.429,289.406,291.426,295.988,298.319,302.862,305.661,307.681,312.207,316.93,319.729,321.749,326.688,331.232,334.031,336.051,338.517,343.494,345.515,350.681,355.577,358.7,363.02,369.293,371.399,373.419,376.729,381.562,385.881,390.072,393.951,397.261,400.103,402.569,407.472,411.738,413.763,416.613,421.435,425.314,427.339,432.187,436.066,440.735,443.578,446.044,450.85,454.729,456.754,459.19,462.547,464.572,469.511,474.054,476.853,478.878,481.649,486.524,488.898,491.164,495.349,497.37,501.375,505.236,509.097,512.976,516.286,519.643,522.071,526.632,528.963,532.842,534.863,541.143,545.965,549.844,554.767" svgx:width="0.31,0.53,0.43,0.23,0.37,0.44,0.82,0.43,0.23,0.55,0.36,0.74,0.63,0.67,0.74,0.23,0.25,0.27,0.47,0.44,0.55,0.53,0.23,0.27,0.55,0.23,0.97,0.43,0.37,0.31,0.43,0.37,0.55,0.23,0.51,0.25,0.51,0.31,0.23,0.51,0.53,0.31,0.23,0.55,0.51,0.31,0.23,0.27,0.55,0.23,0.57,0.54,0.34,0.47,0.69,0.23,0.23,0.37,0.53,0.47,0.47,0.43,0.37,0.31,0.27,0.55,0.47,0.23,0.31,0.53,0.43,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.23,0.27,0.37,0.23,0.55,0.51,0.31,0.23,0.3,0.53,0.25,0.25,0.46,0.23,0.44,0.42,0.42,0.43,0.37,0.37,0.27,0.51,0.25,0.43,0.23,0.69,0.53,0.43,0.55,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">the same n-DYKD ligand in Western blot but not in ELISA, suggesting the peptide is not fully accessible when </text>
   <text y="196.486" x="155.639,158.411,163.217,166.646,170.57,175.376,177.401,180.146,184.79,186.815,189.668,194.493,198.372,200.397,204.285,208.209,211.657,215.104,217.57,221.449,224.842,226.867,231.529,234.805,239.35,242.095,245.974,248.44,253.417,255.442,258.61,263.443,267.277,270.13,274.135,276.16,281.101,285.646,288.445,290.47,293.791,298.615,303.116,309.362,314.339,317.507,319.613,321.638,331.295,335.174,338.603,342.482,344.507,349.34,353.174,356.027,360.033,362.057,365.982,369.258,373.137,375.162,379.023,383.559,388.464,391.821,394.26,397.573,400.318,404.197,409.003,411.802,413.827,420.073,422.431,425.284,430.144,432.169,435.022,439.847,443.726,445.751,450.557,454.436,457.793,460.259,464.57,469.511,473.435,478.241,480.266,484.19,488.996,491.84,494.271,498.978,503.703,508.509,510.975,514.854,518.211,520.236,524.754,527.22,532.162,536.968,539.434,544.339,548.605,550.63,554.581" svgx:width="0.3,0.53,0.37,0.43,0.53,0.23,0.31,0.51,0.23,0.31,0.53,0.43,0.23,0.42,0.44,0.37,0.37,0.27,0.43,0.37,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23,0.35,0.53,0.44,0.31,0.44,0.23,0.55,0.51,0.31,0.23,0.37,0.53,0.51,0.69,0.55,0.35,0.23,0.23,1.07,0.43,0.37,0.43,0.23,0.53,0.44,0.31,0.44,0.23,0.44,0.37,0.43,0.23,0.42,0.51,0.55,0.37,0.27,0.37,0.31,0.43,0.55,0.31,0.23,0.69,0.27,0.31,0.53,0.23,0.31,0.53,0.43,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.43,0.53,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.27,0.43,0.37,0.23,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.44,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">fused to the carrier protein (data not shown). These data are consistent with the designed antibodies binding a </text>
   <text y="206.485" x="155.639,158.897,163.694,167.564,171.371,173.783,178.598,182.405,184.241,187.04,191.846,195.068,198.938,202.763,205.967,210.719,213.131,220.465,224.29,229.141,232.444,234.856,239.338,244.234,248.23,250.507,252.343,256.15,260.632,265.555,268.138,272.62,276.013,283.357,287.137,289.927,292.339,296.821,301.744,303.58,308.062,310.726,312.562,318.907,324.613,330.67,336.925,338.977,340.813,344.737,348.04,349.876,354.367,358.984,363.78,368.37,371.745,375.615,380.367,382.203,384.894,389.484,391.32,394.119,398.889,402.714,404.55,408.375,412.623,415.314,419.139,424.026,428.778,432.647,437.399,439.235,441.512,443.924,448.811,452.69,456.56,459.899,461.735,466.532,470.357,474.974,477.763,480.175,484.927,488.698" svgx:width="0.37,0.52,0.43,0.42,0.27,0.54,0.42,0.23,0.31,0.53,0.37,0.43,0.43,0.36,0.53,0.27,0.82,0.43,0.55,0.37,0.27,0.51,0.55,0.44,0.25,0.23,0.42,0.51,0.55,0.3,0.51,0.37,0.82,0.44,0.31,0.27,0.51,0.55,0.23,0.51,0.3,0.23,0.74,0.63,0.67,0.74,0.23,0.23,0.44,0.37,0.23,0.51,0.52,0.52,0.51,0.37,0.43,0.53,0.23,0.31,0.51,0.23,0.31,0.53,0.43,0.23,0.43,0.47,0.31,0.43,0.55,0.53,0.43,0.53,0.23,0.25,0.27,0.55,0.43,0.44,0.37,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">specific three-dimensional conformation of DYKD, as opposed to the extended linear peptide.</text>
   <text y="226.662" x="155.638,163.217,165.956,170.62,175.471,181.466,186.13,190.794,193.533,199.627" svgx:width="0.69,0.25,0.42,0.44,0.55,0.42,0.42,0.25,0.55,0.56" style="fill:rgb(0,0,0);font-family:Corbel-Bold2;font-size:11.0px;stroke:none;">Discussion</text>
   <text y="236.662" x="155.638,163.539,167.4,169.376,174.19,178.014,182.143,186.004,187.979,192.811,196.672,200.099,202.717,207.234,210.661,218.031,221.936,226.724,228.699,233.215,238.137,241.998,243.974,248.491,251.191,253.166,256.0,260.805,264.666,266.641,271.492,274.812,278.105,280.886,282.861,286.153,290.968,294.811,298.654,302.515,305.807,309.146,311.899,316.758,319.071,321.046,325.834,329.695,337.065,341.582,346.468,349.761,352.585,355.96,359.774,362.599,365.047,369.564,374.451,377.789,379.765,384.282,386.982,388.958,392.819,397.462,399.8,402.526,407.052,411.883,415.744,418.984,422.277,427.109,431.013,434.856,437.304,442.155,445.998,447.972,451.878,456.665,459.489,461.9,466.587,471.293,476.017,480.184,482.16,486.659,489.107,494.029,498.817,501.265,506.151,510.399,512.375,517.027,520.986,524.395,528.299,533.087,535.063,539.58,544.539" svgx:width="0.97,0.43,0.23,0.53,0.44,0.46,0.43,0.23,0.52,0.43,0.37,0.3,0.51,0.37,0.82,0.43,0.53,0.23,0.51,0.55,0.43,0.23,0.51,0.3,0.23,0.31,0.53,0.43,0.23,0.54,0.37,0.37,0.31,0.23,0.37,0.53,0.42,0.42,0.43,0.37,0.37,0.3,0.53,0.25,0.23,0.53,0.43,0.82,0.51,0.55,0.37,0.31,0.37,0.44,0.31,0.27,0.51,0.55,0.37,0.23,0.51,0.3,0.23,0.43,0.52,0.27,0.31,0.51,0.52,0.43,0.36,0.37,0.52,0.43,0.42,0.27,0.54,0.42,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.51,0.44,0.37,0.43,0.53,0.23,0.51,0.55,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">We have performed one of the first successful demonstrations of epitope-specific antibody binding based on </text>
   <text y="236.662" x="546.463,551.035,554.635" svgx:width="0.51,0.4,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:9.0px;stroke:none;">de </text>
   <text y="246.661" x="155.638,160.448,164.642,168.713" svgx:width="0.53,0.47,0.45,0.47" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:9.0px;stroke:none;">novo</text>
   <text y="246.661" x="173.035,175.168,180.001,183.907,187.291,189.784,194.125,199.129,201.262,203.395,209.625,213.009,215.502,220.437,224.73,226.863,229.719,235.896,240.567,242.7,247.533,250.025,255.077,258.983,262.289,266.195,271.031,273.857,275.99,278.348,280.807,285.355,288.775,292.729,296.413,300.625,302.758,306.621,311.322,316.014,319.32,324.039,328.071,331.908,336.761,340.667,344.051,346.184,348.317,354.494,358.4,360.533,363.839,367.792,371.68,376.211,380.39,384.296,387.601,391.555,396.388,398.521,401.188,405.763,410.622,414.043,416.176,421.035,426.039,428.533,433.125,437.985,441.891,444.024,447.978,452.814,455.688,458.148,462.885,467.639,472.472,474.965,478.871,482.255,484.388,490.664,493.052,495.934,500.821,502.954,507.787,510.28,515.333,519.239,522.545,526.451,531.286,534.112,536.245,542.311,548.929,554.518" svgx:width="0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.23,0.23,0.74,0.37,0.27,0.55,0.47,0.23,0.31,0.69,0.51,0.23,0.53,0.27,0.56,0.43,0.37,0.43,0.55,0.31,0.23,0.25,0.27,0.51,0.37,0.44,0.37,0.46,0.23,0.44,0.52,0.52,0.37,0.51,0.44,0.42,0.53,0.43,0.37,0.23,0.23,0.69,0.43,0.23,0.37,0.43,0.42,0.51,0.46,0.43,0.37,0.43,0.53,0.23,0.3,0.51,0.53,0.37,0.23,0.53,0.55,0.27,0.51,0.53,0.43,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.27,0.43,0.37,0.23,0.69,0.27,0.31,0.53,0.23,0.53,0.27,0.56,0.43,0.37,0.43,0.55,0.31,0.23,0.67,0.74,0.62,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;"> design. Using two different library approaches, we recovered four unique antibodies with different CDR </text>
   <text y="256.66" x="155.638,159.011,162.879,167.388,172.167,175.992,180.878,184.685,188.51,191.813,193.55,196.348,201.125,204.903,207.648,209.385,213.262,217.213,220.965,225.771,227.508,231.97,234.382,239.268,244.02,245.757,248.554,253.323,257.148,258.885,262.24,266.109,273.443,277.268,279.005,285.348,291.054,297.111,303.726,305.463,310.258,314.083,318.698,321.486,323.898,328.65,332.475,334.212,338.02,342.501,347.424,350.006,354.486,357.877,365.22,368.998,371.787,374.199,378.679,383.602,385.654,387.391,393.582,395.884,398.681,403.487,405.224,409.049,413.223,417.731,422.51,424.893,428.196,430.499,433.188,437.013,438.75,442.006,446.802,450.671,454.478,456.89,461.705,465.512,467.814,470.585,474.057,476.109,477.846,486.476,491.282,493.737,496.014,499.84,501.577,506.463,510.907,515.001,518.788,521.065,522.802,526.67,531.421,534.21,536.584,541.236,545.905,550.592,554.723" svgx:width="0.37,0.43,0.51,0.53,0.43,0.55,0.42,0.43,0.37,0.23,0.31,0.53,0.44,0.31,0.23,0.43,0.44,0.42,0.53,0.23,0.51,0.27,0.55,0.53,0.23,0.31,0.53,0.43,0.23,0.37,0.44,0.82,0.43,0.23,0.74,0.63,0.67,0.74,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.23,0.42,0.51,0.55,0.3,0.51,0.37,0.82,0.44,0.31,0.27,0.51,0.55,0.23,0.23,0.69,0.27,0.31,0.53,0.23,0.43,0.47,0.51,0.53,0.27,0.37,0.27,0.31,0.43,0.23,0.37,0.52,0.43,0.42,0.27,0.54,0.42,0.27,0.31,0.46,0.23,0.23,0.97,0.53,0.27,0.25,0.43,0.23,0.55,0.51,0.46,0.43,0.25,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">sequences that each bind the same DYKD peptide conformation, with exquisite specificity. While novel antibody </text>
   <text y="266.659" x="155.638,158.912,163.725,167.611,171.436,173.866,178.699,182.524,184.844,187.65,190.08,193.923,197.244,199.197,203.992,207.797,211.909,215.752,217.705,222.373,226.259,230.102,235.043,236.996,240.353,244.149,246.956,249.386,253.884,258.796,262.807,265.145,267.376,271.525,273.478,278.248,282.091,285.412,287.842,292.115,297.018,300.903,305.673,307.626,312.295,316.138,318.737,323.235,326.473" svgx:width="0.37,0.52,0.43,0.42,0.27,0.54,0.42,0.27,0.31,0.27,0.43,0.37,0.23,0.53,0.44,0.46,0.43,0.23,0.51,0.43,0.43,0.55,0.23,0.37,0.44,0.31,0.27,0.51,0.55,0.44,0.25,0.25,0.46,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.43,0.53,0.23,0.51,0.43,0.3,0.51,0.37,0.43" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">specificities have been rationally designed before</text>
   <text y="263.602" x="330.299,333.119" svgx:width="0.48,0.48" style="fill:rgb(0,0,255);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">16</text>
   <text y="263.602" x="335.939,337.284" svgx:width="0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">, </text>
   <text y="263.602" x="338.553,341.373" svgx:width="0.48,0.48" style="fill:rgb(0,0,255);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">26</text>
   <text y="266.662" x="344.189,346.259,348.212,351.027,355.814,359.657,363.048,366.891,368.844,372.739,376.625,379.944,382.239,384.669,388.512,391.869,393.822,397.665,401.931,405.818,413.034,417.703,419.998,423.841,427.162,429.115,431.545,436.313,439.119,442.358,447.045,451.705,456.502,460.327,464.212,468.982,470.935,474.209,479.022,482.908,486.733,489.163,493.996,497.821,500.141,502.928,507.077,509.03,513.475,517.624,519.577,524.347,528.19,531.511,533.941,538.214,543.155,545.585,550.452,554.664" svgx:width="0.23,0.23,0.31,0.53,0.43,0.37,0.43,0.23,0.43,0.44,0.37,0.25,0.27,0.43,0.37,0.23,0.43,0.47,0.44,0.82,0.52,0.25,0.43,0.37,0.23,0.27,0.55,0.31,0.37,0.51,0.53,0.53,0.42,0.43,0.53,0.23,0.37,0.52,0.43,0.42,0.27,0.54,0.42,0.27,0.31,0.46,0.23,0.51,0.46,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.27,0.55,0.47,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">, these earlier examples introduced specificity by designing </text>
   <text y="276.661" x="155.639,160.245,165.336,167.673,171.93,174.198,177.12,182.014,185.965,188.233,195.253,199.699,201.967,208.078,214.735,220.45,222.718,227.035,229.598,233.675,235.943,238.481,243.356,246.269,249.615,254.409,259.176,264.081,268.074,270.987,273.525,278.13,283.179,285.447,290.052,292.842,295.111,299.833,304.015,308.893,312.238,316.853,321.629,326.522,331.191,335.778,338.316,342.249,344.517,349.122,352.587" svgx:width="0.51,0.55,0.25,0.46,0.23,0.31,0.53,0.43,0.23,0.77,0.48,0.23,0.67,0.74,0.62,0.23,0.46,0.27,0.44,0.23,0.27,0.55,0.31,0.37,0.51,0.53,0.53,0.42,0.31,0.27,0.51,0.55,0.23,0.51,0.3,0.23,0.53,0.46,0.53,0.37,0.51,0.52,0.53,0.51,0.51,0.27,0.42,0.23,0.51,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">only the H3 CDR via introduction of hydrophobic or </text>
   <text y="276.661" x="354.855" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:EuclidSymbol;font-size:9.0px;stroke:none;">β</text>
   <text y="276.661" x="359.453,362.783,366.164,369.078,372.543,376.535,381.546,386.424,388.692,391.399,395.401,399.304,402.083,406.988,410.333,414.284,417.713,419.981,422.903,427.805,431.709,434.58,436.848,439.77,443.763,447.154,451.417,455.368,458.239,460.507,462.91,465.448,470.458,474.461,478.454,481.919,484.187,488.138,492.869,495.296,498.111,502.725,507.645,511.596,515.025,517.203,519.471,525.841,528.133,531.055,535.948,540.563,545.468,549.865,554.671" svgx:width="0.36,0.37,0.31,0.37,0.44,0.55,0.53,0.23,0.3,0.43,0.44,0.31,0.53,0.37,0.43,0.37,0.23,0.31,0.53,0.44,0.31,0.23,0.31,0.44,0.37,0.47,0.43,0.31,0.23,0.25,0.27,0.55,0.43,0.44,0.37,0.23,0.43,0.52,0.27,0.31,0.51,0.52,0.43,0.37,0.23,0.23,0.69,0.25,0.31,0.53,0.51,0.53,0.47,0.53,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">-strand features that target linear epitopes. Although </text>
   <text y="286.66" x="155.639,159.455,164.418,168.281,172.145,174.929,177.272,181.361,185.126,187.169,188.897,191.69,196.487,198.866,202.16,203.888,211.217,215.882,220.625,224.441,226.169,230.645,233.3,235.028,239.487,241.89,246.77,251.513,253.916,258.761,262.964,264.692,267.072,270.366,272.094,275.424,279.287,282.504,286.32,288.048,290.625,295.101,298.431,300.159,305.049,308.824,311.472,316.242,319.572,323.562,325.83,327.558,331.422,336.168,338.952,341.322,345.969,350.634,355.377,357.78,361.596,364.89,366.933,368.661,374.641,379.384,384.127,386.425,389.209,391.612,396.088,400.978,404.968,407.284,409.492,412.96,415.003,416.731,419.524,424.287,428.103,429.831,434.308,439.27,441.477,445.599,447.327,451.192,455.938,458.722,461.092,465.739,470.403,475.146,477.549,481.365,484.659,486.387,491.13,494.946,498.24,500.643,504.894,509.775,513.639,518.382,520.11,526.296,528.594,531.387,536.184,537.912,541.164,545.934,549.682,554.487" svgx:width="0.43,0.56,0.43,0.42,0.31,0.27,0.46,0.43,0.23,0.23,0.31,0.53,0.27,0.37,0.23,0.82,0.51,0.53,0.43,0.23,0.51,0.3,0.23,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.27,0.37,0.23,0.37,0.44,0.37,0.43,0.23,0.3,0.51,0.37,0.23,0.55,0.44,0.31,0.53,0.37,0.44,0.25,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.27,0.43,0.37,0.23,0.23,0.69,0.53,0.53,0.27,0.31,0.27,0.51,0.55,0.44,0.25,0.25,0.46,0.23,0.23,0.31,0.53,0.43,0.23,0.51,0.55,0.25,0.46,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.27,0.43,0.37,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.43,0.53,0.23,0.69,0.27,0.31,0.53,0.23,0.37,0.53,0.42,0.53,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">effective, this mode of binding is rare for natural antibodies. Additionally, the only antibodies designed with such </text>
   <text y="296.659" x="155.639,162.995,166.838,169.658,174.449,179.141,183.887,187.208,189.17,193.969,197.78,201.896,205.739,207.701,212.375,216.266,220.109,225.05,227.012,230.333,232.763,237.635,241.931,244.226,248.069,251.291,256.061,260.564,267.929,271.82,274.25,279.191,281.153,285.044,289.818,292.628,295.025,299.7,304.391,309.161,311.591,315.434,318.755,320.717,323.849,326.228,328.298,332.09,334.16,336.122,340.091,342.053" svgx:width="0.82,0.43,0.31,0.53,0.51,0.53,0.37,0.23,0.53,0.44,0.46,0.43,0.23,0.51,0.43,0.43,0.55,0.23,0.37,0.27,0.55,0.47,0.25,0.43,0.36,0.53,0.51,0.82,0.44,0.27,0.55,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.27,0.43,0.37,0.23,0.35,0.27,0.23,0.43,0.23,0.23,0.44,0.23,0.7" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">methods have been single-domain antibodies (i.e. a V</text>
   <text y="298.462" x="348.464" svgx:width="0.77" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">H</text>
   <text y="296.662" x="352.959,354.921,359.691,364.194,371.559,375.451,377.881,382.822,384.784,390.997,393.322,396.143,400.933,405.446,410.138,412.901,414.863,418.832,420.794" svgx:width="0.23,0.53,0.51,0.82,0.44,0.27,0.55,0.23,0.69,0.27,0.31,0.53,0.51,0.53,0.31,0.23,0.44,0.23,0.7" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;"> domain without a V</text>
   <text y="298.462" x="427.155" svgx:width="0.54" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">L</text>
   <text y="296.662" x="430.316,432.279,437.048,441.552,448.917,452.808,455.238,460.179,463.311,465.381,467.343,470.29,475.231,477.193,481.018,485.522,490.294,493.106,496.463,500.408,503.687,506.45,508.52,510.482,516.596,520.439,522.401,527.171,531.014,534.335,536.765,541.043,545.951,549.842,554.594" svgx:width="0.23,0.53,0.51,0.82,0.44,0.27,0.55,0.35,0.23,0.23,0.34,0.55,0.23,0.42,0.51,0.55,0.31,0.37,0.44,0.37,0.31,0.23,0.23,0.69,0.43,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.43,0.53,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;"> domain). In contrast, we designed </text>
   <text y="306.661" x="155.637,159.633,161.954,164.231,166.022,170.504,173.843,175.634,179.009,182.906,187.001,190.826,194.165,198.161,200.438,202.229,208.214,214.748,220.337,223.64,225.431,228.122,232.712,234.503,238.967,241.379,246.266,251.018,252.809,256.067,258.857,262.286,267.065,270.934,273.589,278.368,281.707,285.703,287.98,289.771,294.253,297.592,299.383,301.66,304.072,308.958,312.837,316.707,320.046,321.837,325.662,330.27,332.574,335.264,339.755,344.552,348.377,351.68,353.471,357.899,362.03,363.821,366.404,370.886,374.279,381.65,384.062,388.913,393.125,394.916,398.867,400.658,405.455,410.126,413.879,418.262,422.087,424.832,426.623,429.422,434.201,437.981,440.726,442.517,446.324,450.806,458.006,462.659,464.936,468.761,476.096,479.921,484.673,487.418,490.721,492.512,495.311,500.081,503.906,505.697,509.567,514.319,517.109,519.521,523.661,527.486,532.409,534.2,537.467,542.246,546.026,550.823,554.648" svgx:width="0.44,0.25,0.25,0.23,0.51,0.37,0.23,0.37,0.43,0.46,0.43,0.37,0.44,0.25,0.23,0.67,0.74,0.62,0.37,0.23,0.31,0.51,0.23,0.51,0.27,0.55,0.53,0.23,0.37,0.31,0.37,0.53,0.42,0.31,0.53,0.37,0.44,0.25,0.23,0.51,0.37,0.23,0.25,0.27,0.55,0.43,0.44,0.37,0.23,0.43,0.52,0.27,0.31,0.51,0.52,0.43,0.37,0.23,0.51,0.46,0.23,0.3,0.51,0.37,0.82,0.27,0.55,0.47,0.23,0.44,0.23,0.52,0.51,0.42,0.5,0.43,0.31,0.23,0.31,0.53,0.44,0.31,0.23,0.42,0.51,0.82,0.52,0.25,0.43,0.82,0.43,0.55,0.31,0.37,0.23,0.31,0.53,0.43,0.23,0.44,0.55,0.31,0.27,0.47,0.43,0.55,0.23,0.37,0.53,0.44,0.52,0.43,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">all or several CDRs to bind structural or linear epitopes by forming a pocket that complements the antigen shape </text>
   <text y="316.66" x="155.637,161.86,164.196,167.025,171.863,173.834,176.528,180.349,184.475,188.989,192.359,196.27,200.81,203.118,206.974,208.945,211.388,216.171,218.894,222.75,226.121,230.102,234.004,236.825,239.268,243.782,248.664,251.999,253.97,258.753,261.17,264.459,267.281,270.704,273.112,277.616,282.319,285.041,288.943,293.726,295.697,298.527,303.364,306.618,311.14,315.951,320.257,325.059,329.581,334.283,337.06,339.031,341.86,346.662,350.518,352.489,358.506,365.071,370.692,374.025,375.996,379.898,384.815,389.599,391.57,394.373,398.535,403.175,405.618,409.483,413.51,415.819,417.79,423.806,430.372,435.992,437.963,441.37,445.27,449.811,454.621,458.478,463.396,467.234,471.09,474.425,476.508,478.479,484.703,489.487,492.308,494.715,499.399,504.102,508.885,511.328,515.184,518.519,520.49,524.985,527.429,532.347,537.131,539.574,544.456,548.699,550.67,554.621" svgx:width="0.69,0.27,0.31,0.53,0.23,0.3,0.44,0.46,0.51,0.37,0.44,0.51,0.25,0.43,0.23,0.27,0.55,0.31,0.43,0.37,0.44,0.42,0.31,0.27,0.51,0.55,0.37,0.23,0.53,0.27,0.37,0.31,0.37,0.27,0.51,0.53,0.31,0.43,0.53,0.23,0.31,0.53,0.37,0.51,0.53,0.47,0.53,0.51,0.53,0.31,0.23,0.31,0.53,0.43,0.23,0.67,0.74,0.62,0.37,0.23,0.44,0.55,0.53,0.23,0.31,0.46,0.52,0.27,0.42,0.44,0.25,0.23,0.67,0.74,0.62,0.23,0.37,0.43,0.51,0.53,0.43,0.55,0.42,0.43,0.37,0.23,0.23,0.69,0.55,0.31,0.27,0.51,0.51,0.53,0.27,0.43,0.37,0.23,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.44,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">with favorable interactions distributed throughout the CDRs and typical CDR sequences. Antibodies binding a </text>
   <text y="326.659" x="155.637,160.443,165.168,169.974,173.899,177.789,181.624,186.477,190.356,195.029,197.874,200.34,205.146,209.025,211.059,218.484,220.95,228.375,230.841,234.702,236.736,241.274,243.992,246.026,253.426,257.352,262.329,267.272,271.916,275.345,279.224,281.258,285.119,289.657,294.464,297.319,301.245,303.711,308.688,311.154,316.061,320.327,322.361,326.25,330.175,333.568,338.277,342.859,347.514,351.629,356.435,359.828,363.663,366.409,370.288,373.645,375.679,381.828,385.707,388.985,392.864,394.898,399.704,403.583,406.94,409.406,413.719,418.661,422.586,427.392,429.426,433.91,438.095,440.129,444.134,446.168,449.525,451.991,459.416,461.929,464.288,468.214,471.607,473.641,477.476,482.148,486.811,490.089,494.78,498.785,502.594,507.454,509.488,514.016,518.743,521.542,523.576,526.853,530.779,535.343,540.176,542.642,545.919,549.845,554.597" svgx:width="0.53,0.51,0.53,0.43,0.42,0.44,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.23,0.82,0.27,0.82,0.27,0.42,0.23,0.51,0.3,0.23,0.82,0.44,0.55,0.55,0.51,0.37,0.43,0.23,0.42,0.51,0.55,0.31,0.44,0.27,0.55,0.27,0.55,0.47,0.23,0.42,0.44,0.37,0.51,0.51,0.53,0.46,0.53,0.37,0.44,0.31,0.43,0.37,0.23,0.69,0.43,0.37,0.43,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.43,0.53,0.23,0.51,0.46,0.23,0.44,0.23,0.37,0.27,0.82,0.27,0.25,0.44,0.37,0.23,0.44,0.52,0.52,0.37,0.51,0.44,0.42,0.53,0.23,0.51,0.53,0.31,0.23,0.37,0.43,0.51,0.53,0.27,0.37,0.43,0.53,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">dodecapeptide mimic of mannose containing carbohydrates were designed by a similar approach but required </text>
   <text y="336.658" x="155.637,159.207,163.3,167.59,171.613,175.15,179.343,181.818,184.342,187.76,192.447,197.424,202.507,207.427,210.928,213.452,218.13,220.992,223.516,231.048,235.77,238.245,242.31,246.376,251.396,253.895,257.961,261.498,264.023,268.908,273.261,278.353,282.42,289.989,292.599,296.604,300.105,302.628,307.315,312.129,315.114,317.724,325.293,327.903,331.881,335.857,338.842,341.452,346.13,351.251,353.775,357.84,362.924,367.874,370.398,374.421,378.867,381.753,385.776,390.824,394.325,396.87,401.16,405.183,407.707,412.511,415.929,420.615,423.503,427.526,430.136,435.257,437.781,441.199,445.222,448.001,452.725,455.2,460.15,462.76,467.807,472.217,474.741,478.764,481.715,484.493,489.171,492.796,495.739" svgx:width="0.37,0.43,0.46,0.43,0.37,0.44,0.25,0.23,0.37,0.51,0.53,0.55,0.53,0.37,0.23,0.51,0.3,0.23,0.82,0.51,0.25,0.43,0.42,0.53,0.25,0.44,0.37,0.23,0.53,0.46,0.55,0.44,0.82,0.27,0.42,0.37,0.23,0.51,0.52,0.31,0.27,0.82,0.27,0.42,0.44,0.31,0.27,0.51,0.55,0.23,0.44,0.55,0.53,0.23,0.43,0.47,0.31,0.43,0.55,0.37,0.27,0.46,0.43,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23,0.37,0.43,0.3,0.51,0.25,0.53,0.27,0.55,0.47,0.23,0.43,0.3,0.3,0.51,0.37,0.31,0.37" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">several rounds of molecular dynamics optimization and extensive protein refolding efforts</text>
   <text y="333.602" x="499.164,502.1" svgx:width="0.48,0.48" style="fill:rgb(0,0,255);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">27</text>
   <text y="336.662" x="505.034,507.284,509.808,516.232,521.197,525.22,528.638,532.713,536.833,540.334,542.858,545.853,550.819,554.644" svgx:width="0.23,0.23,0.69,0.53,0.43,0.37,0.43,0.44,0.37,0.23,0.31,0.53,0.43,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">, whereas the </text>
   <text y="346.661" x="155.636,162.01,167.743,173.827,180.469,183.7,188.525,192.377,197.023,199.841,202.28,207.059,210.911,212.882,217.375,219.814,224.73,229.509,231.948,236.828,241.067,243.038,246.937,251.717,254.536,256.941,261.623,266.323,271.102,273.541,277.393,280.723,282.694,285.944,289.796,294.622,299.133,302.591,305.311,309.209,313.988,315.959,320.758,324.61,327.861,331.713,333.684,336.935,340.753,343.056,345.495,349.394,354.173,356.144,359.548,364.104,366.408,370.226,372.468,376.626,378.597,383.108,388.058,390.029,392.857,397.656,401.508,403.479,405.918,410.868,413.201,416.019,418.487,422.512,424.816,426.787,430.621,435.132,442.361,447.007,451.706,454.534,458.343,461.162,463.601,468.112,473.036,477.061,479.365,481.336,486.115,489.967,493.297,495.736,500.022,504.902,508.232,510.203,514.102,519.017,523.796,525.767,529.018,532.87,536.157,541.01,543.208,545.927,549.826,554.578" svgx:width="0.74,0.63,0.67,0.74,0.36,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.23,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.27,0.43,0.37,0.23,0.37,0.43,0.52,0.51,0.37,0.31,0.43,0.53,0.23,0.53,0.43,0.37,0.43,0.23,0.37,0.43,0.25,0.27,0.43,0.53,0.23,0.37,0.51,0.25,0.43,0.25,0.46,0.23,0.51,0.55,0.23,0.31,0.53,0.43,0.23,0.27,0.55,0.27,0.31,0.27,0.44,0.25,0.23,0.42,0.51,0.82,0.52,0.53,0.31,0.44,0.31,0.27,0.51,0.55,0.44,0.25,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.37,0.23,0.44,0.55,0.53,0.23,0.37,0.43,0.37,0.53,0.25,0.31,0.43,0.53,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">DYKD-peptide binding antibodies reported here relied solely on the initial computational designs and resulted </text>
   <text y="356.66" x="155.636,158.048,162.971,164.807,169.613,172.025,176.299,181.105,182.941,187.099,189.511,193.3,195.577,200.302,203.605,205.441,209.923,212.587,214.423,217.006,221.533,223.81,228.562,232.432,237.184,239.02,243.628,246.85,251.341,254.032,257.857,260.269,265.192" svgx:width="0.27,0.55,0.23,0.53,0.27,0.47,0.53,0.23,0.46,0.27,0.43,0.25,0.53,0.37,0.23,0.51,0.3,0.23,0.3,0.51,0.25,0.53,0.43,0.53,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">in high yields of folded protein.</text>
   <text y="366.659" x="167.633,177.259,181.102,184.498,188.341,190.303,197.093,201.732,204.495,210.498,217.054,222.661,224.623,229.253,232.497,236.389,241.159,243.589,247.48,250.292,252.722,257.226,262.099,265.42,267.382,272.183,275.995,280.112,283.955,285.917,289.886,291.848,295.092,298.935,306.302,310.193,313.519,318.001,321.902,326.433,328.669,332.818,334.78,339.604,342.034,346.332,351.156,353.118,356.397,361.194,365.019,368.844,372.687,375.968,379.289,381.251,384.608,388.41,391.123,394.966,396.928,400.821,405.729,410.499,412.461,417.37,421.883,424.704,428.605,433.136,435.431,439.274,441.236,445.079,452.279,456.135,460.104,464.077,467.574,469.644,471.606,477.874,480.065,482.886,487.678,492.191,496.988,501.286,506.11,508.072,510.893,515.685,519.528,521.49,524.847,528.648,531.362,535.205,537.167,541.671,544.353" svgx:width="1.07,0.43,0.37,0.43,0.23,0.75,0.52,0.31,0.67,0.74,0.62,0.23,0.52,0.37,0.43,0.53,0.27,0.42,0.31,0.27,0.51,0.55,0.37,0.23,0.53,0.44,0.46,0.43,0.23,0.44,0.23,0.37,0.43,0.82,0.44,0.37,0.5,0.44,0.51,0.25,0.46,0.23,0.53,0.27,0.47,0.53,0.23,0.37,0.53,0.42,0.42,0.43,0.37,0.37,0.23,0.37,0.44,0.31,0.43,0.23,0.44,0.55,0.53,0.23,0.55,0.51,0.31,0.44,0.51,0.25,0.43,0.23,0.43,0.8,0.42,0.44,0.42,0.46,0.23,0.23,0.69,0.25,0.31,0.53,0.51,0.53,0.47,0.53,0.23,0.31,0.53,0.43,0.23,0.37,0.44,0.31,0.43,0.23,0.51,0.3,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">These OptCDR predictions have a remarkably high success rate and notable efficacy. Although the rate of </text>
   <text y="366.659" x="546.315,550.874,554.474" svgx:width="0.51,0.4,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:9.0px;stroke:none;">de </text>
   <text y="376.658" x="155.636,160.314,164.382,168.322" svgx:width="0.53,0.47,0.45,0.47" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:9.0px;stroke:none;">novo</text>
   <text y="376.658" x="172.502,174.176,178.737,181.913,186.357,189.001,192.781,195.148,200.026,201.7,206.407,210.187,213.445,215.812,220.021,224.899,226.573,229.784,234.518,238.28,242.042,245.822,249.034,252.362,256.142,259.4,261.074,263.412,266.67,268.344,270.711,275.551,279.313,282.489,286.321,290.199,293.457,295.824,300.628,304.82,306.827,308.501,310.758,313.458,315.132,317.471,320.729,322.403,325.614,328.357,330.766,333.041,335.273,336.947,340.709,345.145,352.471,359.759,364.194,369.072,370.746,373.282,377.717,381.011,382.685,385.33,389.11,393.914,397.172,398.846,403.281,406.575,408.249,412.838,417.572,422.412,427.119,430.296,434.118,438.796,442.054,443.728,448.163,450.782,452.456,457.163,460.943,464.201,466.568,470.778,475.583,478.841,480.515,483.159,487.704,489.378,493.983,497.763,499.437,502.765,506.527,509.703,513.526,517.306,522.146,525.969,530.676,532.35,536.956,540.736,543.272,547.707,550.882,554.707" svgx:width="0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.23,0.37,0.53,0.42,0.42,0.43,0.37,0.37,0.43,0.37,0.23,0.27,0.37,0.23,0.27,0.55,0.42,0.37,0.43,0.44,0.37,0.27,0.55,0.47,0.23,0.23,0.27,0.31,0.23,0.27,0.37,0.23,0.37,0.31,0.27,0.25,0.25,0.23,0.42,0.51,0.82,0.82,0.51,0.55,0.23,0.3,0.51,0.37,0.23,0.31,0.43,0.55,0.37,0.23,0.51,0.37,0.23,0.53,0.53,0.55,0.53,0.37,0.43,0.53,0.37,0.23,0.51,0.3,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.37,0.23,0.31,0.51,0.23,0.51,0.43,0.23,0.37,0.42,0.37,0.43,0.43,0.55,0.43,0.53,0.23,0.51,0.43,0.3,0.51,0.37,0.43,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;"> protein design successes is increasing, it is still common for tens or hundreds of designs to be screened before </text>
   <text y="386.657" x="155.636,160.123,165.014,168.848,170.792,174.064,178.839,183.29,189.459,192.767,194.711,197.514,202.289,206.123,208.067,212.823,216.657,219.965,222.381,225.608,229.482,234.239,236.183,240.138,244.013,246.808,249.161,253.36,255.668,258.445" svgx:width="0.51,0.55,0.43,0.23,0.37,0.53,0.51,0.69,0.37,0.23,0.31,0.53,0.43,0.23,0.53,0.43,0.37,0.27,0.37,0.43,0.53,0.23,0.44,0.42,0.31,0.27,0.46,0.27,0.31,0.46" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">one shows the desired activity</text>
   <text y="383.602" x="262.579,265.39" svgx:width="0.48,0.48" style="fill:rgb(0,0,255);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">28</text>
   <text y="386.662" x="268.202,270.258,272.202,278.057,280.806,282.75,286.706,288.65,291.912,294.707,298.14,302.924,306.798,309.459,314.242,317.586,321.586,323.868,325.812,328.093,331.995,336.094,339.889,342.116,344.173,346.117,348.425,351.175,353.119,355.508,358.816,360.76,364.022,368.806,372.239,376.853,380.25,382.64,385.947,388.364,393.22,397.437,399.381,402.184,406.968,410.753,413.502,415.446,418.25,423.06,426.288,430.161,433.995,435.939,440.426,443.099,445.043,449.863,455.052,458.926,462.756,467.684,469.628,474.411,479.339,481.755,486.269,491.057,494.886,496.83,500.669,504.544,509.435,513.922,518.849,521.271,525.109,529.11,531.391,533.335,536.598,539.392,542.826,547.609,551.432" svgx:width="0.23,0.23,0.69,0.31,0.23,0.44,0.23,0.37,0.31,0.37,0.53,0.42,0.31,0.53,0.37,0.44,0.25,0.23,0.25,0.43,0.46,0.43,0.25,0.23,0.23,0.27,0.31,0.23,0.27,0.37,0.23,0.37,0.53,0.37,0.52,0.37,0.27,0.37,0.27,0.55,0.47,0.23,0.31,0.53,0.44,0.31,0.23,0.31,0.53,0.37,0.43,0.43,0.23,0.51,0.3,0.23,0.54,0.58,0.43,0.43,0.55,0.23,0.53,0.55,0.27,0.51,0.53,0.43,0.23,0.42,0.44,0.55,0.51,0.55,0.27,0.42,0.44,0.25,0.23,0.37,0.31,0.37,0.53,0.42,0.36" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">. At a structural level, it is surprising that three of fifteen unique canonical struc-</text>
   <text y="396.661" x="155.639,158.322,163.128,166.377,170.229,172.2,176.034,180.544,187.853,192.345,194.784,199.708,203.516,206.334,208.773,213.283,218.162,221.492,223.463,226.713,230.565,233.85,238.702,240.899,243.618,247.516,252.295,254.266,256.705,261.655,263.626,267.524,272.304,275.122,277.561,281.729,285.581,290.531,293.762,298.254,300.693,305.607,310.386,312.825,317.704,321.943,323.914,328.108,332.006,335.427,337.894,341.792,346.572,349.344,352.674,354.753,356.724,361.342,365.852,369.218,371.189,375.087,379.866,382.684,385.088,389.769,394.468,399.247,401.686,405.538,408.868,410.839,413.558,418.175,420.146,424.827,428.679,430.65,434.872,437.339,441.246,445.782,448.086,451.938,453.909,457.761,462.036,466.861,470.713,474.134,476.573,483.936,487.788,492.568,495.395,499.419,501.723,503.694,508.204,511.57,513.541,516.368,521.165,525.017,528.383,532.191,537.016,540.868,545.567,548.385,550.824,554.63" svgx:width="0.31,0.53,0.37,0.43,0.23,0.42,0.51,0.82,0.51,0.27,0.55,0.44,0.31,0.27,0.51,0.55,0.37,0.23,0.37,0.43,0.37,0.53,0.25,0.31,0.43,0.53,0.23,0.27,0.55,0.23,0.44,0.55,0.31,0.27,0.47,0.43,0.55,0.36,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.46,0.44,0.37,0.27,0.44,0.55,0.31,0.37,0.23,0.23,0.53,0.51,0.37,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.27,0.43,0.37,0.23,0.31,0.51,0.23,0.51,0.43,0.23,0.46,0.27,0.44,0.51,0.25,0.43,0.23,0.43,0.47,0.52,0.43,0.37,0.27,0.82,0.43,0.55,0.31,0.44,0.25,0.23,0.51,0.37,0.23,0.31,0.53,0.43,0.37,0.44,0.52,0.43,0.53,0.31,0.27,0.42,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">ture combinations resulted in antigen-binding variants. For antibodies to be viable experimental or therapeutic </text>
   <text y="406.66" x="155.639,159.545,163.685,167.51,172.262,175.007,178.31,180.362,182.18,184.979,189.749,193.646,197.777,199.595,206.795,211.547,214.805,217.55,219.368,224.165,228.755,232.012,235.387,239.212,242.47,245.773,247.591,251.731,256.402,261.073,265.825,267.643,271.513,278.695,283.618,285.922,288.712,291.124,294.949,298.252,300.07,303.94,308.827,313.579,315.397,320.203,322.615,326.89,331.696,333.514,336.772,341.569,345.438,349.245,351.657,356.472,360.279,362.583,365.373,367.785,371.61,374.913,376.965,378.783,382.653,387.54,392.292,394.11,396.909,401.679,405.504,408.879,412.704,414.522,418.392,423.144,425.934,428.31,432.962,437.633,442.385,444.797,448.622,451.925,453.743,461.078,464.948,468.773,471.518,473.336,476.135,480.905,485.495,488.869,492.694,494.512,498.319,501.712,504.016,506.707,510.532,513.925,516.364,520.315,522.367,524.185,533.788,537.613,539.431,542.014,546.505,551.284,554.623" svgx:width="0.44,0.47,0.43,0.55,0.31,0.37,0.23,0.23,0.31,0.53,0.43,0.46,0.23,0.82,0.53,0.37,0.31,0.23,0.52,0.51,0.37,0.37,0.43,0.37,0.37,0.23,0.47,0.51,0.51,0.53,0.23,0.44,0.8,0.55,0.27,0.31,0.27,0.43,0.37,0.23,0.44,0.55,0.53,0.23,0.53,0.27,0.47,0.53,0.23,0.37,0.52,0.43,0.42,0.27,0.54,0.42,0.27,0.31,0.27,0.43,0.37,0.23,0.23,0.44,0.55,0.53,0.23,0.31,0.53,0.43,0.37,0.43,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.27,0.43,0.37,0.23,0.82,0.43,0.43,0.31,0.23,0.31,0.53,0.51,0.37,0.43,0.23,0.42,0.37,0.27,0.31,0.43,0.37,0.27,0.44,0.23,0.23,1.07,0.43,0.23,0.3,0.51,0.53,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">agents, they must possess good affinities and high specificities, and these antibodies meet those criteria. The four </text>
   <text y="416.659" x="155.639,158.99,163.859,167.756,171.653,175.568,178.92,182.313,185.124,190.042,192.409,194.578,199.42,203.335,206.728,209.23,213.581,218.525,221.918,224.087,228.929,232.844,236.313,240.21,243.696,246.167,250.914,254.877,259.719,261.888,266.752,270.667,273.982,277.897,280.066,283.981,288.319,293.215,295.686,300.243,302.641,305.476,307.645,311.114,315.029,319.973,323.366,325.765,328.648,331.091,335.28,339.195,341.364,345.921,348.423,353.405,358.247,360.749,365.693,370.026,372.168,374.337,380.659,385.555,388.057,391.903,396.799,398.968,405.223,409.241,412.634,414.803,418.118,422.091,426.132,430.974,433.525,435.832,440.053,442.222,447.064,450.979,453.764,457.728,461.691,464.584,468.557,473.16,475.527,479.442,481.611,485.484,488.319,490.488,494.385,498.961,503.942,507.839,511.754,516.6,519.484,522.913,526.787,529.671,532.173,536.748,541.693,545.086,547.255,551.831,554.495" svgx:width="0.37,0.53,0.42,0.42,0.43,0.37,0.37,0.3,0.53,0.25,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.37,0.23,0.53,0.43,0.37,0.42,0.37,0.27,0.51,0.43,0.53,0.23,0.53,0.43,0.37,0.43,0.23,0.43,0.47,0.53,0.27,0.51,0.27,0.31,0.23,0.37,0.43,0.55,0.37,0.27,0.31,0.27,0.46,0.43,0.23,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.23,0.69,0.53,0.27,0.42,0.53,0.23,0.69,0.44,0.37,0.23,0.37,0.43,0.44,0.53,0.27,0.25,0.46,0.23,0.53,0.43,0.31,0.43,0.42,0.31,0.44,0.51,0.25,0.43,0.23,0.44,0.31,0.23,0.42,0.51,0.55,0.42,0.43,0.55,0.31,0.37,0.44,0.31,0.27,0.51,0.55,0.37,0.23,0.51,0.3,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">successful designs described here exhibit sensitive binding, which was readily detectable at concentrations of </text>
   <text y="426.658" x="155.639,159.968,164.657,168.986,173.315,174.467,179.399,187.427,189.38,191.801,196.733,198.686,203.807,208.658,211.736,216.011,222.239,224.192,228.956,232.268,234.689,239.553,243.774,245.727,250.356,255.144,258.55,260.971,265.795,269.678,274.439,276.392,280.986,284.878,289.459,291.412,296.032,299.268,303.771,306.476,310.31,312.731,317.595,320.907,322.86,326.744,331.644,336.405,338.358,343.024,347.816,351.735,355.888,359.722,362.935,367.696,370.094,373.365,378.03,380.348,384.15,388.222,392.105,396.866,398.819,402.206,406.022,410.769,414.945,416.898,420.781,425.545,428.349,430.737,435.403,440.086,444.788,448.928,450.881,453.477,457.971,461.378,468.734,472.527,475.281,478.593,480.654,482.607,492.255,494.653,497.965,499.918,503.153,506.987,510.258,515.094,517.277,520.031,521.984,525.8,530.294,535.06,537.862,541.211,545.148,548.419,551.173,554.476" svgx:width="0.48,0.52,0.48,0.48,0.23,0.55,0.89,0.23,0.27,0.55,0.23,0.57,0.54,0.34,0.47,0.69,0.23,0.53,0.37,0.27,0.55,0.47,0.23,0.52,0.53,0.37,0.27,0.54,0.43,0.53,0.23,0.53,0.44,0.51,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.37,0.23,0.44,0.55,0.53,0.23,0.52,0.53,0.44,0.47,0.43,0.36,0.53,0.27,0.37,0.52,0.25,0.44,0.46,0.43,0.53,0.23,0.37,0.42,0.53,0.46,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.3,0.51,0.37,0.82,0.44,0.31,0.37,0.23,0.23,1.07,0.27,0.37,0.23,0.37,0.43,0.37,0.53,0.25,0.31,0.23,0.42,0.51,0.55,0.31,0.37,0.44,0.37,0.31,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">4–50 nM in ELISA using purified Fab proteins and phage-displayed scFv antibody formats. This result contrasts </text>
   <text y="436.657" x="155.639,161.831,164.135,166.934,171.74,173.549,177.356,181.838,189.209,196.544,201.026,205.949,207.758,210.98,214.805,218.063,222.886,225.055,227.8,231.103,232.912,235.666,238.888,243.37,250.741" svgx:width="0.69,0.27,0.31,0.53,0.23,0.42,0.51,0.82,0.82,0.51,0.55,0.23,0.37,0.43,0.37,0.53,0.25,0.31,0.37,0.23,0.3,0.37,0.51,0.82,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">with common results from </text>
   <text y="436.657" x="252.55,257.086,260.686,262.513,267.238,271.351,275.338" svgx:width="0.51,0.4,0.23,0.53,0.47,0.45,0.47" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:9.0px;stroke:none;">de novo</text>
   <text y="436.657" x="279.56,281.369,286.121,289.946,293.249,295.661,299.917,304.804,308.674,313.426,315.235,319.699,322.111,326.997,331.749,334.161,339.012,343.224,345.033,347.445,352.197,354.888,358.713,362.106,364.77,368.721,372.528,376.353,379.656,381.708,383.517,389.744,394.55,396.962,400.715,405.521,407.33,412.082,415.34,420.146,424.142,426.463,428.678,432.809,434.618,438.443,442.691,447.497,449.873,454.337,456.641,459.386,461.195,468.566,470.978,474.785,478.007,482.489,489.824,494.351,496.655,500.525,503.864,505.673,510.137,512.549,517.436,522.188,524.6,529.451,533.663,535.472,539.342,546.524,551.447" svgx:width="0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.43,0.53,0.23,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.27,0.55,0.31,0.43,0.37,0.3,0.44,0.42,0.43,0.37,0.23,0.23,0.69,0.53,0.27,0.42,0.53,0.23,0.53,0.37,0.53,0.44,0.25,0.25,0.46,0.23,0.43,0.47,0.53,0.27,0.51,0.27,0.31,0.23,0.82,0.27,0.42,0.37,0.51,0.82,0.51,0.25,0.44,0.37,0.23,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.44,0.8,0.55,0.36" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;"> designed binding interfaces, which usually exhibit micromolar binding affin-</text>
   <text y="446.656" x="155.639,158.01,160.868,163.352,167.244" svgx:width="0.27,0.31,0.27,0.43,0.37" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">ities</text>
   <text y="443.602" x="170.61" svgx:width="0.48" style="fill:rgb(0,0,255);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">5</text>
   <text y="446.662" x="173.462,175.541,179.479,184.434,189.253,191.332,194.622,198.559,203.136,207.982,210.466,213.756,217.648,219.727,223.62,227.94,232.804,236.701,240.161,242.641,250.043,253.936,258.756,261.622,265.686,268.03,270.109,274.048,281.297,286.288,288.659,291.5,295.698,297.777,305.189,309.037,311.76,316.606,320.013,323.861,326.719,329.198,333.748,338.738,340.817,343.576,348.233,350.312,354.335,358.156,363.029,365.509,369.473,373.637,377.529,379.608,384.573,388.51,393.465,398.014,405.418,410.012,412.383,416.321,419.732,421.811,426.343,428.822,433.777,438.597,441.076,445.995,450.279,452.358,456.295,463.545,468.54,470.911,473.769,476.249,480.141" svgx:width="0.23,0.44,0.55,0.53,0.23,0.37,0.43,0.51,0.53,0.27,0.37,0.43,0.23,0.43,0.47,0.52,0.43,0.37,0.27,0.82,0.43,0.55,0.31,0.44,0.25,0.23,0.44,0.8,0.55,0.27,0.31,0.46,0.23,0.82,0.44,0.31,0.53,0.37,0.44,0.31,0.27,0.51,0.55,0.23,0.31,0.51,0.23,0.44,0.42,0.53,0.27,0.43,0.46,0.43,0.23,0.55,0.44,0.55,0.51,0.82,0.51,0.25,0.44,0.37,0.23,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.44,0.8,0.55,0.27,0.31,0.27,0.43,0.37" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;"> and require experimental affinity maturation to achieve nanomolar binding affinities</text>
   <text y="443.602" x="483.449,486.301" svgx:width="0.48,0.48" style="fill:rgb(0,0,255);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">29</text>
   <text y="446.662" x="489.153,491.273,493.352,498.891,502.857,506.983,511.533,516.487,521.308,523.387,526.829,530.722,535.64,539.012,541.383,544.241,546.653,550.815,554.64" svgx:width="0.23,0.23,0.59,0.43,0.46,0.51,0.55,0.53,0.23,0.37,0.43,0.55,0.37,0.27,0.31,0.27,0.46,0.43,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">. Beyond sensitive </text>
   <text y="456.661" x="155.64,160.071,162.447,167.301,172.017,174.393,179.21,183.415,185.431,187.132,189.897,194.634,198.423,201.764,205.553,207.254,209.803,214.261,219.004,222.307,224.008,228.724,232.513,235.78,238.156,242.379,247.197,250.464,252.165,256.0,259.189,262.978,264.679,268.642,270.858,274.199,278.753,280.454,285.224,287.6,291.842,296.659,298.839,302.934,304.635,307.86,312.623,316.46,320.231,322.607,327.386,331.157,332.858,335.407,339.856,343.159,344.86,347.625,352.361,356.15,357.851,361.622,366.176,370.4,375.262,379.009,381.666,385.455,387.156,393.467,399.137,405.158,411.737,413.438,418.202,421.991,426.575,429.331,431.707,436.423,440.161,442.177,443.878,447.768,451.035,452.736,456.599,460.66,464.449,469.336,471.037,474.808,479.257,484.075,487.416,491.205,494.772,498.903,502.649,505.406,507.721,511.782,515.571,517.272,520.992,525.737,529.573,534.391,538.498,542.287,545.554,547.255,549.913,554.503" svgx:width="0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.23,0.31,0.53,0.43,0.37,0.43,0.23,0.3,0.51,0.53,0.37,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.37,0.23,0.44,0.37,0.43,0.23,0.44,0.25,0.37,0.51,0.23,0.53,0.27,0.47,0.53,0.25,0.46,0.23,0.37,0.52,0.43,0.42,0.27,0.54,0.42,0.23,0.3,0.51,0.37,0.23,0.31,0.53,0.43,0.23,0.42,0.51,0.47,0.55,0.44,0.31,0.43,0.23,0.74,0.63,0.67,0.74,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.23,0.23,0.44,0.37,0.23,0.43,0.46,0.43,0.55,0.23,0.42,0.51,0.55,0.37,0.43,0.37,0.46,0.44,0.31,0.27,0.46,0.43,0.23,0.42,0.53,0.44,0.55,0.47,0.43,0.37,0.23,0.31,0.51,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">binding, these four designs are also highly specific for the cognate DYKD peptide, as even conservative changes to </text>
   <text y="466.66" x="155.64,158.43,163.227,165.603,168.897,170.625,173.991,177.852,182.352,187.122,190.938,195.816,199.614,203.43,205.158,209.028,213.483,216.696,221.277,225.48,229.251,231.934,235.794,240.537,242.265,246.72,249.123,254.001,258.744,261.147,265.989,270.192,271.92,275.025,279.777,282.18,286.383,289.677" svgx:width="0.31,0.53,0.27,0.37,0.23,0.37,0.43,0.51,0.53,0.43,0.55,0.42,0.43,0.23,0.44,0.51,0.37,0.51,0.47,0.44,0.31,0.43,0.53,0.23,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.35,0.53,0.27,0.47,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">this sequence abrogated binding (Figs </text>
   <text y="466.66" x="291.396" svgx:width="0.48" style="fill:rgb(0,0,255);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">3</text>
   <text y="466.66" x="295.707,297.435,301.296,306.174,310.917" svgx:width="0.23,0.44,0.55,0.53,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;"> and </text>
   <text y="466.66" x="312.645" svgx:width="0.48" style="fill:rgb(0,0,255);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">4</text>
   <text y="466.66" x="316.956,320.061,322.104,323.832,332.454,337.251,339.699,341.967,345.783,347.511,352.389,356.205,358.5,361.29,366.051,369.867,373.197,374.925,381.684,386.292,389.028,395.004,401.529,407.109,408.837,413.436,416.649,420.51,425.253,427.656,431.517,434.298,436.701,441.174,446.016,449.31,451.038,455.916,460.39,463.72,465.448,470.047,473.26,477.121,481.864,484.267,488.128,490.81,494.671,499.414,501.142,505.596,508.0,512.878,517.62,520.023,524.865,529.068,530.797,538.122,542.784,547.527,551.343,554.646" svgx:width="0.35,0.23,0.23,0.97,0.53,0.27,0.25,0.43,0.23,0.55,0.43,0.27,0.31,0.53,0.43,0.37,0.23,0.75,0.52,0.31,0.67,0.74,0.62,0.23,0.52,0.37,0.43,0.53,0.27,0.42,0.31,0.27,0.51,0.55,0.37,0.23,0.55,0.51,0.37,0.23,0.52,0.37,0.43,0.53,0.27,0.42,0.31,0.43,0.53,0.23,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.82,0.51,0.53,0.43,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">). While neither OptCDR predictions nor predicted binding modes </text>
   <text y="476.659" x="155.64,158.223,162.705,166.044,167.781,172.551,177.033,184.368,188.895,191.172,195.762,200.19,204.321,206.058,213.393,218.063,222.815,226.604,228.854,232.157,233.894,237.764,240.986,244.811,246.548,250.373,254.621,259.418,263.288,267.157,269.848,273.718,278.47,280.207,282.898,287.488,289.225,292.447,296.326,300.277,304.03,308.836,310.573,314.353,317.044,321.526,328.897,331.309,335.116,336.853,339.13,343.027,347.122,350.911,353.188,354.925,359.533,362.755,366.625,370.432,372.817,376.12,378.532,383.013,387.936,389.988,391.725,394.524,399.294,403.119,404.856,407.268,412.02,414.711,418.536,421.875,425.826,429.696,432.486,434.898,439.38,444.231,447.534,449.271,453.924,457.749,460.521,466.614,470.483,474.308,479.231,480.968,487.313,493.019,499.076,505.691,507.428,511.298,516.185,520.937,522.674,526.544,531.296,534.086,536.462,541.114,545.785,550.474,554.605" svgx:width="0.3,0.51,0.37,0.23,0.53,0.51,0.82,0.51,0.25,0.51,0.47,0.46,0.23,0.82,0.51,0.53,0.43,0.25,0.37,0.23,0.44,0.37,0.43,0.23,0.43,0.47,0.52,0.43,0.42,0.31,0.43,0.53,0.23,0.31,0.51,0.23,0.37,0.43,0.44,0.42,0.53,0.23,0.44,0.31,0.51,0.82,0.27,0.42,0.23,0.25,0.43,0.46,0.43,0.25,0.23,0.52,0.37,0.43,0.42,0.27,0.37,0.27,0.51,0.55,0.23,0.23,0.31,0.53,0.43,0.23,0.27,0.55,0.31,0.43,0.37,0.44,0.42,0.31,0.27,0.51,0.55,0.37,0.23,0.51,0.43,0.31,0.69,0.43,0.43,0.55,0.23,0.74,0.63,0.67,0.74,0.23,0.44,0.55,0.53,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">for homology models are expected to reach atomic level precision, the interactions between DYKD and antibody </text>
   <text y="486.658" x="155.64,159.447,163.938,168.762,171.039,175.791,177.627,182.28,186.105,187.941,191.28,195.06,197.85,200.262,204.744,209.64,213.636,215.913,218.325,222.105,225.975,230.727,232.779,234.615,237.333,242.004,244.659,249.438,252.66,256.485,258.321,262.146,267.114,271.596,275.025,277.77,281.073,282.909,285.321,290.244,292.08,295.887,300.477,303.681,307.488,311.088,315.219,318.477,321.276,325.272,327.594,329.871,332.283,336.063,339.843,342.633,345.045,349.527,354.45,356.286,362.478,364.934,367.256,369.533,371.369,375.977,379.199,383.645,387.839,390.251,395.003,398.828,400.664,404.615,409.367,414.119,416.422,419.212,421.624,426.106,431.002,434.998,437.275,439.111,441.523,446.374,449.677,452.089,456.363,460.998,463.743" svgx:width="0.42,0.51,0.53,0.25,0.53,0.23,0.51,0.43,0.23,0.37,0.44,0.31,0.27,0.51,0.55,0.44,0.25,0.27,0.42,0.43,0.53,0.23,0.23,0.3,0.53,0.31,0.53,0.37,0.43,0.23,0.43,0.56,0.51,0.37,0.31,0.37,0.23,0.27,0.55,0.23,0.42,0.51,0.36,0.42,0.37,0.46,0.37,0.31,0.44,0.25,0.25,0.27,0.42,0.44,0.31,0.27,0.51,0.55,0.23,0.69,0.27,0.25,0.25,0.23,0.52,0.37,0.51,0.46,0.27,0.53,0.43,0.23,0.44,0.53,0.53,0.27,0.31,0.27,0.51,0.55,0.44,0.25,0.23,0.27,0.55,0.37,0.27,0.47,0.53,0.31,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">could be rationalized; future efforts in co-crystallization will provide additional insight.</text>
   <text y="496.657" x="167.637,175.535,180.129,183.464,187.446,192.004,196.212,200.149,203.033,205.198,207.43,210.341,215.223,219.161,221.393,227.85,233.669,239.838,246.565,248.797,253.706,257.644,262.373,265.275,267.799,272.664,276.601,278.833,282.726,287.455,292.364,296.355,300.338,303.735,307.15,309.382,312.185,316.887,319.119,323.696,326.22,331.22,336.084,338.316,342.38,344.612,347.982,352.891,356.873,360.793,363.317,368.244,372.163,374.395,379.008,381.532,386.612,391.107,395.09,399.954,402.186,406.106,410.701,415.735,418.431,423.025,426.531,433.987,437.88,440.782,443.306,447.9,452.936,455.168,457.971,462.674,464.906,467.817,472.699,476.636,478.868,483.733,487.67,491.086,493.61,497.979,502.978,506.961,511.825,514.057,518.04,522.904,525.806,528.295,533.06,537.844,542.707,545.232,549.169,552.585,554.637" svgx:width="0.89,0.51,0.37,0.43,0.51,0.46,0.43,0.37,0.23,0.23,0.31,0.53,0.43,0.23,0.74,0.63,0.67,0.74,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.23,0.44,0.52,0.52,0.43,0.44,0.37,0.37,0.23,0.31,0.51,0.23,0.51,0.27,0.55,0.53,0.23,0.44,0.23,0.37,0.52,0.43,0.42,0.27,0.54,0.42,0.23,0.5,0.27,0.55,0.5,0.43,0.53,0.23,0.42,0.51,0.55,0.3,0.51,0.37,0.82,0.44,0.31,0.27,0.51,0.55,0.23,0.31,0.51,0.23,0.31,0.53,0.43,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.43,0.53,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.27,0.43,0.37,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">Moreover, the DYKD peptide appears to bind a specific kinked conformation to the designed antibodies. </text>
   <text y="506.656" x="155.64,159.864,162.285,167.184,171.0,174.834,176.787,180.669,185.433,188.235,190.623,195.288,199.971,204.672,208.812,210.765,215.242,217.663,222.563,227.324,229.745,234.607,238.828,240.781,244.016,247.898,252.418,257.206,259.627,262.862,266.696,270.008,271.961,274.773,279.554,283.388,285.341,290.151,293.985,298.614,301.416,303.837,308.598,312.432,314.385,319.05,322.884,324.837,329.503,331.818,335.778,339.594,343.476,348.237,350.19,353.982,356.736,358.689,361.5,366.282,370.116,372.069,377.001,380.214,382.918,386.752,390.157,397.537,399.958,404.723,409.486,412.798,414.751,419.246,421.919,423.872,426.684,431.465,435.299,437.252,441.099,444.981,448.385,451.791,454.212,458.046,461.394,463.347,467.967,471.201,475.704,478.408,482.242,484.663,489.595,491.656,493.609,496.03,500.793,503.497,507.331,510.679,514.639,518.521,521.322,523.743,528.237,533.101,536.413,538.366,544.569,546.886,549.697,554.503" svgx:width="0.47,0.27,0.55,0.42,0.43,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.37,0.43,0.51,0.53,0.27,0.37,0.43,0.37,0.23,0.31,0.53,0.43,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.23,0.51,0.43,0.23,0.52,0.25,0.44,0.42,0.43,0.53,0.23,0.44,0.31,0.23,0.31,0.53,0.43,0.23,0.55,0.36,0.31,0.43,0.37,0.82,0.27,0.55,0.53,0.37,0.23,0.51,0.3,0.23,0.31,0.53,0.43,0.23,0.42,0.44,0.37,0.37,0.27,0.43,0.37,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23,0.23,0.27,0.55,0.31,0.43,0.37,0.44,0.42,0.31,0.27,0.51,0.55,0.37,0.23,0.69,0.27,0.31,0.53,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">Since antibody binding requires the peptide be placed at the n-terminus of the carrier protein, interactions with </text>
   <text y="516.655" x="155.64,158.501,163.332,167.22,169.272,173.167,177.099,180.553,184.008,186.483,190.371,193.773,195.825,200.494,203.777,208.33,211.082,214.97,217.445,222.431,224.483,229.153,232.437,236.325,239.644,244.486,251.891,255.831,260.401,262.677,266.871,268.923,271.398,276.384,281.135,285.977,289.865,294.814,298.684,302.572,304.624,307.484,312.315,316.203,318.255,323.113,327.001,331.679,334.532,337.007,341.822,345.71,347.762,351.632,356.175,361.161,363.805,368.348,371.802,379.208,383.05,385.901,388.376,392.919,397.905,400.02,402.072,411.774,414.22,417.586,419.638,424.163,426.638,431.587,436.402,438.877,443.789,448.064,450.116,457.512,462.244,467.059,470.947,472.999,476.84,481.519,486.377,490.317,494.248,497.595,500.961,503.013,507.872,512.525,515.844,519.21,521.647,526.218,528.558,532.39,534.505,536.557,540.542,543.909,545.961,550.018,552.401,554.678" svgx:width="0.31,0.53,0.43,0.23,0.42,0.44,0.37,0.37,0.27,0.43,0.37,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23,0.52,0.37,0.43,0.37,0.53,0.82,0.44,0.51,0.25,0.46,0.23,0.27,0.55,0.53,0.53,0.43,0.55,0.42,0.43,0.23,0.31,0.53,0.43,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.23,0.42,0.51,0.55,0.3,0.51,0.37,0.82,0.44,0.31,0.27,0.51,0.55,0.23,0.23,1.07,0.27,0.37,0.23,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.82,0.51,0.53,0.43,0.23,0.44,0.52,0.52,0.43,0.44,0.37,0.37,0.23,0.52,0.51,0.37,0.37,0.27,0.51,0.25,0.43,0.23,0.23,0.44,0.37,0.23,0.44,0.25,0.25,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">the carrier protein presumably influence the peptide conformation. This binding mode appears possible, as all </text>
   <text y="526.654" x="155.64,158.864,163.607,167.378,171.149,174.938,178.162,181.429,184.113,188.903,191.144,192.845,199.578,204.161,206.87,212.819,219.319,224.872,226.573,231.289,235.078,238.345,240.721,244.944,249.761,253.028,254.729,257.105,261.822,264.479,268.268,271.571,275.486,279.322,282.031,283.732,289.89,292.16,294.924,299.694,301.395,307.705,313.375,319.396,325.975,327.676,330.9,335.643,339.362,344.132,345.833,348.597,353.343,357.087,359.797,361.497,364.262,368.998,372.787,374.488,378.324,383.042,385.798,388.139,392.757,397.394,402.049,406.144,407.845,411.033,414.822,418.089,420.465,425.074,429.817,433.606,436.873,438.574,443.29,447.844,449.545,454.398,458.856,461.565,463.266,466.985,469.254,473.143,476.376,481.146,482.847,489.004,491.275,494.039,498.809,500.51,503.274,508.01,511.799,513.5,517.299,521.135,524.494,527.852,530.228,534.017,537.32,539.021,543.595,546.783,551.337" svgx:width="0.37,0.53,0.42,0.42,0.43,0.37,0.37,0.3,0.53,0.25,0.23,0.75,0.52,0.31,0.67,0.74,0.62,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.37,0.23,0.27,0.55,0.31,0.43,0.37,0.44,0.42,0.31,0.23,0.69,0.27,0.31,0.53,0.23,0.74,0.63,0.67,0.74,0.23,0.37,0.53,0.42,0.53,0.23,0.31,0.53,0.44,0.31,0.23,0.31,0.53,0.43,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.37,0.43,0.37,0.27,0.53,0.53,0.43,0.37,0.23,0.53,0.51,0.23,0.55,0.51,0.31,0.23,0.42,0.25,0.44,0.37,0.53,0.23,0.69,0.27,0.31,0.53,0.23,0.31,0.53,0.43,0.23,0.42,0.44,0.37,0.37,0.27,0.43,0.37,0.23,0.52,0.37,0.51,0.36" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">successful OptCDR designs interact with DYKD such that the antibody residues do not clash with the carrier pro-</text>
   <text y="536.653" x="155.64,158.322,162.138,164.541,169.455,171.183,175.656,178.986,180.714,185.457,187.832,191.126,194.545,199.206,203.814,206.55,208.278,213.065,216.881,221.488,224.268,226.671,231.414,235.23,238.425,242.249,246.109,249.492,252.876,255.279,259.095,262.425,264.153,268.751,271.964,276.445,279.126,282.942,285.345,290.259,291.987,294.39,299.132,301.813,305.629,308.959,312.901,316.761,319.541,321.944,326.416,331.257,334.551,336.594,338.322,347.952,350.328,353.622,355.35,357.753,362.495,365.177,368.993,372.412,377.01,380.222,384.038,386.827,390.598,393.378,395.781,400.253,405.167,406.895,410.881,413.121,416.487,421.068,422.796,426.612,430.852,435.495,437.789,441.649,444.052,448.894,452.188,453.916,460.135,464.724,468.846,470.574,473.363,478.123,481.939,483.667,488.41,492.226,495.52,497.923,502.17,507.047,510.907,515.65,517.378,521.239,525.982,528.762,531.128,535.771,540.432,545.175,547.578,551.394,554.696" svgx:width="0.31,0.43,0.27,0.55,0.23,0.51,0.37,0.23,0.53,0.27,0.37,0.37,0.53,0.52,0.31,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.36,0.42,0.44,0.37,0.37,0.27,0.43,0.37,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23,0.27,0.55,0.31,0.43,0.37,0.44,0.42,0.31,0.27,0.51,0.55,0.37,0.23,0.23,1.07,0.27,0.37,0.23,0.27,0.55,0.31,0.43,0.37,0.52,0.37,0.43,0.31,0.44,0.31,0.27,0.51,0.55,0.23,0.44,0.25,0.37,0.51,0.23,0.43,0.47,0.52,0.25,0.44,0.27,0.55,0.37,0.23,0.69,0.53,0.46,0.23,0.31,0.53,0.43,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.43,0.53,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.27,0.43,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">tein or disrupt peptide-carrier protein interactions. This interpretation also explains why the designed antibodies </text>
   <text y="546.652" x="155.64,158.898,163.677,167.484,171.291,175.116,178.374,181.677,184.395,189.219,191.541,193.755,197.886,199.794,204.447,208.938,213.717,218.604,223.356,225.264,229.746,234.714,236.928,241.059,242.967,246.837,251.76,253.668,258.591,261.795,264.485,268.31,271.703,279.074,281.486,286.382,290.378,292.655,294.563,300.908,306.614,312.671,319.286,321.194,325.064,329.951,334.703,336.611,341.363,343.775,348.527,350.435,355.322,359.813,362.558,364.466,368.93,371.342,376.229,380.981,382.889,385.688,390.458,394.283,396.191,398.468,400.88,405.767,409.646,413.516,416.854,418.762,423.37,426.592,431.083,433.774,437.599,440.011,444.934,446.842,451.324,456.247,458.155,462.106,464.014,471.88,475.705,478.963,481.654,485.479,488.872,493.795,495.703,500.212,502.489,506.98,509.725,511.777,513.685,516.61,521.533,523.441,527.248,531.731,536.482,539.272,542.611,546.535,549.793,552.538,554.59" svgx:width="0.37,0.53,0.42,0.42,0.43,0.37,0.37,0.3,0.53,0.25,0.25,0.46,0.23,0.51,0.51,0.53,0.55,0.53,0.23,0.51,0.55,0.25,0.46,0.23,0.44,0.55,0.23,0.55,0.36,0.31,0.43,0.37,0.82,0.27,0.55,0.44,0.25,0.23,0.74,0.63,0.67,0.74,0.23,0.44,0.55,0.53,0.23,0.53,0.27,0.53,0.23,0.55,0.51,0.31,0.23,0.51,0.27,0.55,0.53,0.23,0.31,0.53,0.43,0.23,0.25,0.27,0.55,0.43,0.44,0.37,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23,0.51,0.55,0.23,0.44,0.23,0.97,0.43,0.37,0.31,0.43,0.37,0.55,0.23,0.51,0.25,0.51,0.31,0.23,0.23,0.34,0.55,0.23,0.42,0.51,0.55,0.31,0.37,0.44,0.37,0.31,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">successfully bound only an n-terminal DYKD and did not bind the linear protein on a Western blot. In contrast, </text>
   <text y="556.651" x="155.64,158.444,163.218,167.048,168.992,172.803,177.29,184.665,192.004,195.834,199.06,202.876,205.319,209.319,211.601,213.545,221.568,225.893,227.837,231.711,236.468,239.262,241.643,246.3,250.976,255.669,259.149,261.205,263.149,269.382,274.192,276.609,280.366,285.177,287.121,289.511,292.818,294.762,299.266,304.158,308.608,314.805,319.732,321.676,324.372,328.971,330.915,335.383,337.8,342.691,347.448,349.392,353.347,355.291,357.573,359.989,364.881,368.764,372.639,375.982,377.926,382.692,387.619,393.591,400.03,401.974,406.776,410.605,415.227,418.021,420.438,425.194,429.024,430.968,435.616,440.4,443.797,446.214,451.069,455.286,457.23,465.1,468.93,472.192,474.888,478.717,482.115,487.042,488.986,493.501,495.782,500.278,502.937,505.732,508.148,513.004,517.247,519.304,521.248,525.077,529.33,534.14,536.521,540.989,543.298,545.993,549.868,554.62" svgx:width="0.31,0.53,0.43,0.23,0.42,0.51,0.82,0.82,0.43,0.37,0.42,0.27,0.44,0.25,0.23,0.89,0.48,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.23,0.69,0.53,0.27,0.42,0.53,0.23,0.27,0.37,0.23,0.5,0.55,0.51,0.69,0.55,0.23,0.31,0.51,0.23,0.51,0.27,0.55,0.53,0.23,0.44,0.23,0.25,0.27,0.55,0.43,0.44,0.37,0.23,0.53,0.54,0.69,0.71,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.23,0.53,0.53,0.37,0.27,0.55,0.47,0.23,0.97,0.43,0.37,0.31,0.43,0.37,0.55,0.23,0.51,0.25,0.51,0.31,0.31,0.27,0.55,0.47,0.23,0.23,0.43,0.47,0.53,0.27,0.51,0.27,0.31,0.43,0.53,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">the commercial M1 antibody, which is known to bind a linear FLAG peptide during Western blotting, exhibited </text>
   <text y="566.65" x="155.64,158.44,163.212,167.037,168.981,173.474,178.093,182.891,187.481,190.784,193.089,195.781,199.606,201.55,206.313,210.094,212.751,215.443,219.268,222.662,227.585,229.637,231.581,241.185,245.01,246.954,250.223,255.003,258.785,263.583,267.408,269.352,273.159,277.642,284.844,289.497,291.774,295.599,302.936,306.761,311.515,314.315,318.187,321.581,323.886,326.659,330.79,332.734,340.07,343.895,346.686,350.08,352.492,356.299,358.243,360.828,365.311,368.65,370.594,373.394,378.165,381.99,383.934,388.733,392.558,397.176,399.968,402.38,407.132,410.957,414.161,419.273,424.385,427.049,431.369,435.689,437.741,442.061,444.005,447.877,452.631,455.422,457.798,462.453,467.125,471.816,475.947,477.891,480.303,485.056,487.749,491.574,494.913,498.864,502.735,505.526,507.938,512.422,517.345,519.289,525.454,529.38,532.683,534.627,536.904,541.351,547.445,551.27,554.609" svgx:width="0.31,0.53,0.43,0.23,0.51,0.52,0.52,0.51,0.37,0.27,0.31,0.43,0.23,0.52,0.44,0.31,0.31,0.43,0.37,0.55,0.23,0.23,1.07,0.43,0.23,0.37,0.53,0.44,0.52,0.43,0.23,0.42,0.51,0.82,0.52,0.25,0.43,0.82,0.43,0.55,0.31,0.44,0.37,0.27,0.31,0.46,0.23,0.82,0.43,0.31,0.37,0.27,0.42,0.23,0.3,0.51,0.37,0.23,0.31,0.53,0.43,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.36,0.57,0.57,0.3,0.48,0.48,0.23,0.48,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.27,0.55,0.31,0.43,0.37,0.44,0.42,0.31,0.27,0.51,0.55,0.23,0.69,0.44,0.37,0.23,0.25,0.51,0.69,0.43,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">the opposite pattern. The shape complementarity metric for the peptide-EEf15.4 antibody interaction was lower </text>
   <text y="576.649" x="155.64,158.4,163.14,166.971,171.858,173.554,175.9,179.167,180.868,183.601,187.696,192.265,194.641,198.435,202.392,204.674,206.85,210.945,212.646,215.981,219.812,223.601,228.488,230.189,232.733,237.176,240.479,242.18,246.937,250.726,255.304,258.055,260.431,265.147,268.936,272.104,275.934,280.648,283.398,285.735,290.348,294.98,299.63,303.725,305.421,309.192,313.635,320.795,325.409,327.65,331.439,335.576,339.365,342.632,344.333,347.411,351.695,353.711,357.995,362.279,366.563,368.264,372.319,376.108,379.354,382.573,387.285,390.552,392.249,396.533,398.549,402.833,407.117,410.195,412.211,413.912,418.085,420.461,425.308,429.079,432.868,434.565,437.793,442.532,446.274,451.031,454.82,456.521,460.292,464.735,471.896,476.509,478.75,482.539,489.835,493.624,498.337,501.096,504.927,508.281,510.545,513.278,517.373,519.074,522.845,527.287,530.641,533.824,537.573,539.838,543.578,546.23,550.061,554.813" svgx:width="0.31,0.53,0.44,0.55,0.23,0.27,0.37,0.23,0.31,0.46,0.52,0.27,0.42,0.44,0.25,0.25,0.46,0.23,0.37,0.43,0.43,0.55,0.23,0.3,0.51,0.37,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.36,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.42,0.51,0.82,0.52,0.25,0.43,0.47,0.43,0.37,0.23,0.35,0.48,0.23,0.48,0.48,0.48,0.23,0.46,0.43,0.37,0.37,0.53,0.37,0.23,0.48,0.23,0.48,0.48,0.35,0.23,0.23,0.47,0.27,0.55,0.42,0.43,0.23,0.37,0.53,0.44,0.52,0.43,0.23,0.42,0.51,0.82,0.52,0.25,0.43,0.82,0.43,0.55,0.31,0.44,0.37,0.27,0.31,0.46,0.23,0.42,0.51,0.37,0.37,0.43,0.25,0.44,0.31,0.43,0.53,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">than is typically seen for peptide-antibody complexes (0.585 versus 0.75). Since shape complementarity correlated </text>
   <text y="586.648" x="155.64,161.868,164.208,167.042,171.884,173.864,177.77,184.988,189.947,192.286,195.094,199.261,201.241,205.93,209.791,212.482,215.208,219.069,222.444,224.424,227.259,232.074,235.979,240.938,242.918,246.823,251.575,255.742,257.722,262.248,265.083,269.888,273.749,277.124,279.104,283.604,286.052,290.578,295.267,299.901,304.068,307.407,309.855,313.725,317.757,320.07,322.05,326.847,330.752,334.127,338.032,345.403,349.264,351.99,355.851,359.226,361.206,363.654,368.613,370.593,374.58,376.56,381.203,384.461,388.393,392.623,395.071,399.598,404.385,407.724,409.704,413.609,418.541,422.573,424.822,428.989,432.328,434.749,438.088,440.068,444.586,447.286,449.266,451.516,455.683,459.093,463.665,467.481,471.675,479.045,482.906,484.886,489.385,491.833,496.756,501.544,503.992,508.878,513.126,515.106,519.722,523.637,528.245" svgx:width="0.69,0.27,0.31,0.53,0.23,0.44,0.8,0.55,0.27,0.31,0.46,0.23,0.51,0.43,0.31,0.31,0.43,0.37,0.23,0.31,0.53,0.44,0.55,0.23,0.44,0.55,0.46,0.23,0.51,0.31,0.53,0.43,0.37,0.23,0.51,0.27,0.51,0.52,0.53,0.46,0.37,0.27,0.42,0.44,0.25,0.23,0.52,0.44,0.37,0.44,0.82,0.43,0.31,0.43,0.37,0.23,0.27,0.55,0.23,0.44,0.23,0.52,0.37,0.43,0.46,0.27,0.51,0.53,0.37,0.23,0.44,0.55,0.44,0.25,0.46,0.37,0.27,0.37,0.23,0.51,0.3,0.23,0.25,0.46,0.37,0.51,0.42,0.46,0.82,0.43,0.23,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.53,0.44,0.51,0.37" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">with affinity better than any other biophysical parameter in a previous analysis of lysozyme binding Fabs</text>
   <text y="583.602" x="531.512,534.343" svgx:width="0.48,0.48" style="fill:rgb(0,0,255);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">30</text>
   <text y="586.662" x="537.174,539.262,541.242,544.076,548.918,551.338,554.641" svgx:width="0.23,0.23,0.31,0.53,0.27,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">, this </text>
   <text y="596.661" x="155.637,162.981,166.77,170.901,172.737,177.39,181.215,183.051,187.002,188.838,193.59,196.965,200.79,203.508,208.332,210.609,212.445,219.78,223.605,226.395,229.788,232.2,236.007,237.843,240.534,245.124,246.96,251.568,254.961,257.373,261.855,265.248,267.552,270.342,272.754,276.534,280.359,282.195,286.02,290.628,292.932,295.623,300.114,304.911,308.736,311.94,315.197,319.994,323.864,327.671,330.083,334.898,338.705,340.541,344.412,349.163,351.953,354.329,358.982,363.653,368.342,372.473,374.309,379.061,382.886,386.189,388.601,392.857,397.708,401.011,402.847,405.259,410.182,412.018,414.817,419.587,423.412,425.248,427.966,432.637,435.292,440.071,443.293,447.064" svgx:width="0.82,0.44,0.46,0.23,0.51,0.43,0.23,0.44,0.23,0.53,0.37,0.43,0.3,0.53,0.25,0.23,0.82,0.43,0.31,0.37,0.27,0.42,0.23,0.31,0.51,0.23,0.52,0.37,0.27,0.51,0.37,0.27,0.31,0.27,0.42,0.43,0.23,0.43,0.52,0.27,0.31,0.51,0.52,0.43,0.36,0.37,0.52,0.43,0.42,0.27,0.54,0.42,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.37,0.23,0.27,0.55,0.23,0.31,0.53,0.43,0.23,0.3,0.53,0.31,0.53,0.37,0.43,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">may be a useful metric to prioritize epitope-specific antibody designs in the future.</text>
   <text y="606.66" x="167.634,173.915,176.119,178.953,183.757,188.284,193.099,197.409,202.251,204.226,209.374,214.575,219.417,223.773,228.129,230.217,234.573,236.661,238.641,243.789,248.99,253.832,258.188,262.544,264.632,268.988,270.964,276.112,281.26,283.96,288.316,292.672,294.76,299.116,301.091,304.996,309.919,314.707,316.682,321.83,326.978,329.678,334.034,338.39,340.478,344.834,348.821,350.797,355.296,357.744,362.666,367.454,369.434,375.813,381.555,387.648,394.299,396.275,399.568,404.4,408.304,412.147,414.595,419.446,423.315,427.346,429.702,431.952,436.118,438.094,442.0,446.921,451.709,453.689,459.916,462.255,465.089,469.931,471.911,474.611,478.435,482.565,487.082,490.457,494.371,498.915,501.228,505.089,507.065,510.97,518.188,523.147,525.486,528.31,530.758,534.619,537.958,540.046,542.022,546.548,551.363,554.702" svgx:width="0.69,0.25,0.31,0.53,0.51,0.53,0.47,0.53,0.23,0.57,0.57,0.53,0.48,0.48,0.23,0.48,0.23,0.23,0.57,0.57,0.53,0.48,0.48,0.23,0.48,0.23,0.57,0.57,0.3,0.48,0.48,0.23,0.48,0.23,0.44,0.55,0.53,0.23,0.57,0.57,0.3,0.48,0.48,0.23,0.48,0.44,0.23,0.51,0.27,0.55,0.53,0.23,0.74,0.63,0.67,0.74,0.23,0.37,0.52,0.43,0.42,0.27,0.54,0.42,0.44,0.25,0.25,0.46,0.23,0.44,0.55,0.53,0.23,0.69,0.27,0.31,0.53,0.23,0.3,0.44,0.46,0.51,0.37,0.44,0.51,0.25,0.43,0.23,0.44,0.8,0.55,0.27,0.31,0.27,0.43,0.37,0.23,0.23,0.51,0.53,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">Although EEh13.6, EEh14.3 EEf15.4 and EEf15.4a bind DYKD specifically and with favorable affinities, our </text>
   <text y="616.659" x="155.637,160.479,164.394,167.787,170.289,174.637,179.65,181.81,186.509,189.822,194.584,198.481,202.396,205.744,209.137,211.297,216.139,218.641,223.483,225.643,230.621,235.203,238.038,240.198,244.113,248.451,253.195,255.562,258.064,261.961,264.356,267.246,269.551,273.772,275.932,279.973,284.815,289.657,292.97,296.885,300.234,303.627,305.787,310.486,313.799,318.38,321.162,325.077,327.579,332.592,334.752,337.426,342.044,344.411,349.253,351.755,356.697,360.999,363.159,367.733,371.162,373.322,376.671,379.561,383.531,388.086,390.634,393.001,395.396,398.259,402.48,404.64,407.116,410.465,413.814,418.683,422.598,425.991,428.133,430.293,435.144,437.646,441.022,444.371,447.206,449.348,451.508,454.01,459.023,461.183,464.073,468.933,472.848,475.008,480.21,485.467,490.363,492.523,494.89,497.357,501.913,505.342,509.303,512.994,516.559,518.701,520.861,525.434,530.492,532.797,537.018,539.178,541.852,546.434,551.303,554.642" svgx:width="0.53,0.43,0.37,0.27,0.47,0.55,0.23,0.52,0.37,0.51,0.42,0.43,0.37,0.37,0.23,0.53,0.27,0.53,0.23,0.55,0.51,0.31,0.23,0.43,0.47,0.52,0.25,0.27,0.42,0.27,0.31,0.25,0.46,0.23,0.44,0.53,0.53,0.37,0.43,0.37,0.37,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23,0.3,0.51,0.25,0.53,0.27,0.55,0.47,0.23,0.51,0.37,0.23,0.37,0.31,0.44,0.51,0.27,0.25,0.27,0.31,0.46,0.23,0.27,0.37,0.37,0.53,0.43,0.37,0.23,0.23,0.53,0.27,0.37,0.37,0.31,0.23,0.23,0.27,0.55,0.23,0.31,0.53,0.43,0.23,0.57,0.57,0.53,0.23,0.25,0.27,0.51,0.37,0.44,0.37,0.46,0.23,0.23,0.51,0.55,0.25,0.46,0.23,0.3,0.51,0.53,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">design process did not explicitly address protein folding or stability issues. First, in the EEh library, only four </text>
   <text y="626.658" x="155.637,160.206,162.96,165.102,167.989,172.845,176.76,178.902,181.68,185.595,190.608,192.75,196.591,198.958,203.526,208.5,212.415,215.808,217.95,221.865,226.203,231.099,233.563,238.113,240.504,243.283,247.239,252.081,254.223,257.616,260.118,267.579,270.122,272.514,276.47,279.899,282.041,286.937,289.439,293.8,298.696,300.838,303.205,307.189,311.37,315.247,317.583,320.976,323.118,327.687,330.441,332.583,336.498,340.836,345.531,348.84,352.755,356.099,359.492,361.994,366.564,371.577,373.719,375.861,378.72,384.899,389.579,391.721,396.291,399.045,401.187,407.502,412.398,414.9,418.739,423.635,425.777,430.517,435.095,439.964,444.938,449.78,451.922,458.355,464.151,470.298,477.003,479.145,485.424,487.814,490.7,495.596,497.738,502.634,505.136,509.498,514.394,516.536,519.88,524.764,528.721,532.618,535.12,540.025,543.922,546.313,549.172,552.733,554.785" svgx:width="0.51,0.3,0.23,0.31,0.53,0.43,0.23,0.31,0.43,0.55,0.23,0.42,0.25,0.51,0.55,0.43,0.37,0.23,0.43,0.47,0.53,0.27,0.51,0.27,0.31,0.43,0.53,0.23,0.37,0.27,0.82,0.27,0.25,0.44,0.37,0.23,0.53,0.27,0.47,0.53,0.23,0.25,0.43,0.46,0.43,0.25,0.37,0.23,0.51,0.3,0.23,0.43,0.47,0.52,0.37,0.43,0.37,0.37,0.27,0.51,0.55,0.23,0.23,0.31,0.69,0.51,0.23,0.51,0.3,0.23,0.69,0.53,0.27,0.42,0.53,0.23,0.51,0.51,0.53,0.55,0.53,0.23,0.74,0.63,0.67,0.74,0.23,0.69,0.27,0.31,0.53,0.23,0.53,0.27,0.47,0.53,0.23,0.37,0.52,0.43,0.42,0.27,0.54,0.42,0.27,0.31,0.46,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">of the ten clones exhibited similar high levels of expression, two of which bound DYKD with high specificity. </text>
   <text y="636.657" x="155.637,160.062,163.965,167.808,172.323,177.242,181.974,184.062,186.033,190.322,193.697,197.6,202.916,205.364,210.248,214.496,216.467,222.488,229.055,234.68,238.019,239.99,242.438,247.224,249.947,254.573,256.544,259.331,262.706,266.61,273.978,277.907,284.034,288.549,291.885,296.385,299.724,301.695,305.562,309.465,314.424,316.395,321.081,324.942,326.913,330.205,333.028,336.489,341.304,345.208,347.895,352.71,356.085,360.113,362.469,364.715,368.882,370.853,375.641,378.059,381.398,384.861,389.565,394.215,397.038,399.42,403.548,407.409,409.38,413.284,418.204,422.992,426.007,430.522,433.897,435.868,439.124,443.026,447.568,452.383,454.831,458.087,461.948,463.919,467.762,472.277,479.51,484.34,488.201,493.084,496.474,500.288,503.11,505.558,510.442,514.69,516.661,520.447,525.259,529.162,534.047,538.219,542.08,545.419,547.39,550.113,554.703" svgx:width="0.47,0.43,0.42,0.51,0.55,0.53,0.23,0.23,0.47,0.37,0.44,0.58,0.27,0.55,0.47,0.23,0.67,0.74,0.62,0.37,0.23,0.27,0.55,0.31,0.51,0.23,0.3,0.37,0.44,0.82,0.43,0.69,0.51,0.37,0.5,0.37,0.23,0.42,0.44,0.55,0.23,0.51,0.43,0.23,0.37,0.31,0.37,0.53,0.42,0.31,0.53,0.37,0.44,0.25,0.25,0.46,0.23,0.53,0.27,0.37,0.37,0.53,0.52,0.31,0.27,0.46,0.43,0.23,0.44,0.55,0.53,0.33,0.51,0.37,0.23,0.37,0.43,0.51,0.53,0.27,0.37,0.43,0.23,0.42,0.51,0.82,0.52,0.43,0.55,0.37,0.44,0.31,0.27,0.55,0.47,0.23,0.42,0.53,0.44,0.55,0.47,0.43,0.37,0.23,0.31,0.51,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">Second, grafting CDRs into frameworks can be structurally disruptive and/or require compensating changes to </text>
   <text y="646.656" x="155.637,158.474,161.894,165.847,173.264,177.245,183.421,187.987,191.372,195.917,198.05,201.355,205.261,208.645,211.138,215.866,220.726,224.632" svgx:width="0.3,0.37,0.44,0.82,0.43,0.69,0.51,0.37,0.5,0.23,0.37,0.43,0.37,0.27,0.53,0.53,0.43,0.37" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">framework residues</text>
   <text y="643.602" x="228.031,230.892" svgx:width="0.48,0.48" style="fill:rgb(0,0,255);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">31</text>
   <text y="646.662" x="233.756,235.889,238.022,244.566,249.141,252.023,255.986,260.577,262.875,266.432,268.565,270.698,275.803,278.847,285.363" svgx:width="0.23,0.23,0.74,0.51,0.31,0.44,0.51,0.25,0.46,0.23,0.23,0.56,0.34,0.71,0.47" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">. Notably, PIGS</text>
   <text y="643.602" x="289.713,292.574" svgx:width="0.48,0.48" style="fill:rgb(0,0,255);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">26</text>
   <text y="646.662" x="295.437,297.57,301.524,306.494,311.327,313.46,319.159,323.829,327.287,331.193,333.932,336.814,340.846,347.121,351.956,354.829,357.288,362.024,366.778,371.55" svgx:width="0.23,0.44,0.55,0.53,0.23,0.62,0.51,0.37,0.43,0.31,0.31,0.44,0.69,0.55,0.31,0.27,0.51,0.51,0.53,0.46" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;"> and RosettaAntibody</text>
   <text y="643.602" x="375.768,378.629" svgx:width="0.48,0.48" style="fill:rgb(0,0,255);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">32</text>
   <text y="646.662" x="381.492,383.625,388.317,391.622,395.574,400.407,402.9,406.853,409.628,413.581,418.414,420.547,427.973,431.927,434.42,439.424,441.557,445.393,450.256,454.208,456.702,461.706,463.839,468.385,471.69,475.653,479.732,484.277,487.661,489.794,492.287,497.291,499.424,502.882,506.754,509.112,513.066,517.019,519.845,521.978,528.829,533.528,536.354,542.42,549.037,554.626" svgx:width="0.23,0.52,0.37,0.43,0.53,0.27,0.42,0.31,0.43,0.53,0.23,0.82,0.44,0.27,0.55,0.23,0.42,0.53,0.44,0.27,0.55,0.23,0.51,0.37,0.43,0.44,0.5,0.37,0.23,0.27,0.55,0.23,0.37,0.43,0.25,0.43,0.42,0.31,0.23,0.75,0.52,0.31,0.67,0.74,0.62,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;"> predicted main chain breaks in select OptCDR </text>
   <text y="656.661" x="155.637,160.439,164.313,167.665,170.126,174.433,179.333,182.685,184.696,187.86,192.688,196.518,199.366,203.367,205.377,210.314,214.854,217.649,219.66,222.977,227.796,232.292,238.532,243.505,246.668,248.77,250.781,254.089,258.917,263.232,267.421,271.296,274.603,277.442,279.904,284.804,289.066,291.077,293.925,298.744,302.619,304.63,307.938,310.777,314.255,319.083,323.003,325.707,330.535,333.806,337.681,341.034,343.045,350.438,354.276,358.457,360.468,365.171,369.045,371.057,375.902,380.623,385.154,388.507,390.77,394.95,396.961,404.355,408.184,410.925,414.727,419.547,423.465,428.267,430.278,433.019,437.659,439.67,442.518,447.337,451.212,453.223,458.052,462.988,467.789,471.663,475.016,477.279,481.487,483.947,488.848,493.109,495.121,497.924,501.313,505.232,512.616,516.563,522.705,527.237,530.588,535.102,537.203,539.215,548.903,551.338,554.641" svgx:width="0.53,0.43,0.37,0.27,0.47,0.55,0.37,0.23,0.35,0.53,0.44,0.31,0.44,0.23,0.55,0.51,0.31,0.23,0.37,0.53,0.51,0.69,0.55,0.35,0.23,0.23,0.37,0.53,0.47,0.47,0.43,0.37,0.31,0.27,0.55,0.47,0.23,0.31,0.53,0.43,0.23,0.37,0.31,0.37,0.53,0.42,0.31,0.53,0.37,0.43,0.37,0.23,0.82,0.44,0.46,0.23,0.51,0.43,0.23,0.52,0.51,0.51,0.37,0.25,0.46,0.23,0.82,0.44,0.31,0.42,0.53,0.43,0.53,0.23,0.31,0.51,0.23,0.31,0.53,0.43,0.23,0.53,0.55,0.53,0.43,0.37,0.25,0.46,0.27,0.55,0.47,0.23,0.3,0.37,0.44,0.82,0.43,0.69,0.51,0.37,0.5,0.23,0.23,1.07,0.27,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">designs (data not shown), suggesting the structures may be poorly matched to the underlying framework. This </text>
   <text y="666.66" x="155.637,158.085,162.873,165.601,169.462,172.928,177.572,180.831,184.692,187.528,191.344,194.171,196.619,201.137,206.096,208.076,210.497,213.836,215.816,219.111,223.819,228.473,233.306,237.825,241.291,244.019,247.925,252.713,254.693,259.158,263.325,265.305,268.141,272.948,276.809,278.789,282.047,285.953,290.634,295.449,299.292,303.199,307.987,309.967,312.803,317.61,321.471,324.901,332.282,336.314,338.627,340.607,343.902,346.738,350.654,355.154,357.647,359.96,362.301,365.109,369.276,371.256,375.775,378.475,380.455,385.073,388.989,393.597,395.577,400.725,405.873,410.67,415.026,419.382,421.47,425.826,427.806,431.767,435.106,437.086,440.929,445.448,452.684,457.482,461.389,464.648,468.554,473.342,475.322,478.05,482.676,484.656,487.492,492.298,496.159,498.139,502.937,506.844,510.103,513.964,518.753,521.534" svgx:width="0.27,0.55,0.31,0.43,0.37,0.52,0.37,0.43,0.31,0.44,0.31,0.27,0.51,0.55,0.23,0.27,0.37,0.23,0.37,0.53,0.52,0.52,0.51,0.37,0.31,0.43,0.53,0.23,0.51,0.46,0.23,0.31,0.53,0.43,0.23,0.37,0.43,0.53,0.53,0.42,0.43,0.53,0.23,0.31,0.53,0.43,0.37,0.82,0.44,0.25,0.23,0.37,0.31,0.44,0.51,0.27,0.25,0.27,0.31,0.46,0.23,0.51,0.3,0.23,0.53,0.44,0.51,0.23,0.57,0.57,0.53,0.48,0.48,0.23,0.48,0.23,0.44,0.37,0.23,0.42,0.51,0.82,0.52,0.44,0.37,0.43,0.53,0.23,0.31,0.51,0.23,0.31,0.53,0.43,0.23,0.52,0.44,0.37,0.43,0.55,0.31,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">interpretation is supported by the reduced thermal stability of Fab EEF15.4 as compared to the parent </text>
   <text y="666.66" x="523.514" svgx:width="0.64" style="fill:rgb(0,0,0);font-family:EuclidSymbol;font-size:9.0px;stroke:none;">α</text>
   <text y="666.66" x="529.254,534.402,539.55,541.53,546.148,550.063,554.635" svgx:width="0.57,0.57,0.23,0.53,0.44,0.51,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">EE Fab </text>
   <text y="676.659" x="155.637,158.751,163.512,165.924,170.166,172.218" svgx:width="0.35,0.53,0.27,0.47,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">(Fig. </text>
   <text y="676.659" x="174.168" svgx:width="0.48" style="fill:rgb(0,0,255);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">5</text>
   <text y="676.659" x="178.488,181.602,183.654,185.598,190.272,194.862,199.004,202.829,205.631,210.404,214.229,217.004,219.056,221.0,223.802,228.575,232.4,235.778,239.603,241.547,246.328,250.111,252.913,256.864,258.808,262.068,266.847,271.116,275.259,279.084,282.345,285.09,287.034,289.836,294.618,298.401,301.146,303.09,305.811,310.485,313.142,317.921,321.147,324.972,326.916,333.687,338.306,341.051,347.036,353.573,359.162,361.106,365.858,369.683,372.986,375.398,379.658,384.511,387.814,389.758,393.595,397.469,402.392,404.336,408.991,412.816,414.76,417.172,424.375,428.986,432.211,436.659,440.758,444.631,449.383,451.327,455.757,459.888,461.832,465.21,469.017,472.242,476.114,479.939,484.862,487.274,492.129,496.341,498.285,504.27,510.807,516.396,518.34,521.717,525.59,530.102,534.881,538.706,543.596,547.403,551.228,554.531" svgx:width="0.35,0.23,0.23,0.62,0.51,0.47,0.43,0.31,0.53,0.43,0.37,0.23,0.23,0.31,0.53,0.43,0.37,0.43,0.23,0.53,0.44,0.31,0.44,0.23,0.37,0.53,0.47,0.47,0.43,0.37,0.31,0.23,0.31,0.53,0.44,0.31,0.23,0.3,0.53,0.31,0.53,0.37,0.43,0.23,0.75,0.52,0.31,0.67,0.74,0.62,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.37,0.23,0.42,0.44,0.55,0.23,0.51,0.43,0.23,0.27,0.82,0.52,0.37,0.51,0.46,0.43,0.53,0.23,0.51,0.46,0.23,0.37,0.42,0.37,0.43,0.43,0.55,0.27,0.55,0.47,0.23,0.67,0.74,0.62,0.23,0.37,0.43,0.51,0.53,0.43,0.55,0.42,0.43,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">). Together, these data suggest that future OptCDR designs can be improved by screening CDR sequences </text>
   <text y="686.658" x="155.637,158.346,162.955,166.42,168.701,171.941,174.479,177.719,180.001,183.349,187.345,192.116,197.021,200.954,204.95,209.828,212.108,216.141,220.533,224.916,228.265,232.216,236.554,240.46,243.377,245.915,250.523,255.572,257.853,262.776,267.394,270.211,274.162,279.04,281.957,284.522,288.644,290.993,293.171,295.452,298.692,301.23,303.768,307.008,309.289,313.222,317.831,325.157,330.044,333.95,336.866,339.368,343.958,346.542,348.945,351.375,354.273,358.53,360.811,367.129,369.56,372.485,377.417,379.698,382.623,387.52,391.471,393.752,397.829,401.762,405.695,409.646,414.39,417.207,421.816,425.281,427.561,430.441,433.906,437.902,445.363,449.387,455.606,460.215,463.644,468.234,470.515,474.512,479.525,484.403,486.683,489.923,492.461,494.999,497.537,500.777,503.058,505.596,512.922,517.81,521.887,525.883,528.754,531.035,535.643,540.692,542.973,545.898,550.795,554.62" svgx:width="0.3,0.51,0.37,0.23,0.35,0.27,0.35,0.23,0.37,0.43,0.53,0.53,0.42,0.43,0.53,0.23,0.44,0.47,0.47,0.37,0.43,0.47,0.44,0.31,0.27,0.51,0.55,0.23,0.52,0.51,0.31,0.43,0.55,0.31,0.27,0.44,0.25,0.23,0.23,0.35,0.27,0.27,0.35,0.23,0.42,0.51,0.82,0.52,0.44,0.31,0.27,0.51,0.27,0.25,0.27,0.31,0.46,0.23,0.69,0.27,0.31,0.53,0.23,0.31,0.53,0.43,0.23,0.44,0.42,0.42,0.43,0.52,0.31,0.51,0.37,0.23,0.3,0.37,0.44,0.82,0.43,0.69,0.51,0.37,0.5,0.23,0.44,0.55,0.53,0.23,0.35,0.27,0.27,0.27,0.35,0.23,0.27,0.82,0.52,0.44,0.42,0.31,0.23,0.51,0.55,0.23,0.31,0.53,0.43,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">for (i) reduced aggregation potential, (ii) compatibility with the acceptor framework and (iii) impact on the </text>
   <text y="696.657" x="155.637" svgx:width="0.7" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">V</text>
   <text y="698.462" x="162.025" svgx:width="0.54" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">L</text>
   <text y="696.662" x="165.211,168.478" svgx:width="0.36,0.7" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">-V</text>
   <text y="698.462" x="174.862" svgx:width="0.77" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">H</text>
   <text y="696.662" x="179.382,181.434,183.909,188.722,191.473,195.361,198.814,201.541,205.555,209.425,213.313,215.365,220.187,224.201,228.014,232.574,235.049,239.96,244.235,246.287,250.218,255.129,259.464,261.804,265.636,267.751,269.803,273.817,275.869,278.596,282.61,286.54,289.29,293.833,297.235,299.287,303.847,308.794,313.3,319.552,324.538,326.59,329.341,333.994,336.046,340.76,344.648,346.7,349.175,356.435,361.291,365.834,369.322,372.181,376.112,380.924,383.732,385.784,388.535,393.188,395.24,399.909,403.191,407.741,412.599,416.487,419.889,421.941,427.989,434.583,440.235,442.287,447.144,451.797,455.163,457.528,460.378,462.853,467.395,472.381,474.856,479.768" svgx:width="0.23,0.27,0.55,0.31,0.43,0.37,0.3,0.44,0.42,0.43,0.23,0.52,0.44,0.42,0.5,0.27,0.55,0.47,0.23,0.44,0.55,0.47,0.25,0.43,0.23,0.23,0.44,0.23,0.3,0.44,0.42,0.31,0.51,0.37,0.23,0.5,0.55,0.51,0.69,0.55,0.23,0.31,0.51,0.23,0.51,0.43,0.23,0.27,0.82,0.52,0.51,0.37,0.31,0.44,0.55,0.31,0.23,0.31,0.51,0.23,0.52,0.37,0.51,0.52,0.43,0.37,0.23,0.67,0.74,0.62,0.23,0.52,0.51,0.37,0.27,0.31,0.27,0.51,0.55,0.27,0.55,0.47" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;"> interface packing angle, a factor known to be important to proper CDR positioning</text>
   <text y="693.602" x="483.907,486.756" svgx:width="0.48,0.48" style="fill:rgb(0,0,255);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">10</text>
   <text y="693.602" x="489.605,490.979" svgx:width="0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">, </text>
   <text y="693.602" x="492.307,495.156" svgx:width="0.48,0.48" style="fill:rgb(0,0,255);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">33</text>
   <text y="696.662" x="498.0,500.115,502.167,506.898,511.551,513.603,517.617,522.432,527.247,530.528,534.416,537.735,541.101,543.153,546.012,550.841,554.666" svgx:width="0.23,0.23,0.62,0.51,0.23,0.44,0.53,0.53,0.37,0.43,0.37,0.37,0.23,0.31,0.53,0.43,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">. To address the </text>
   <text y="706.661" x="155.64,157.935,161.706,164.352,167.034,170.85,174.18,175.908,178.67,184.754,189.335,191.063,194.861,199.334,204.212,208.01,211.826,215.21,220.052,223.346,225.389,227.117,233.201,237.017,238.745,241.958,245.819,249.617,253.433,258.176,260.966,263.171,267.293,269.021,273.764,277.652,281.738,285.518,287.786,292.268,297.056,300.917,305.66,307.388,311.33,313.058,317.828,321.599,324.389,328.259,332.867,336.782,340.148,343.964,345.692,350.166,352.821,354.549,361.875,366.537,371.172,375.987,378.282,382.143,385.473,387.201,391.062,395.805,398.586,400.953,405.597,410.258,414.939,419.061,420.789,425.541,429.402,432.822,435.558" svgx:width="0.25,0.44,0.31,0.31,0.43,0.37,0.23,0.31,0.69,0.51,0.23,0.42,0.51,0.55,0.42,0.43,0.37,0.55,0.37,0.23,0.23,0.69,0.43,0.23,0.37,0.43,0.42,0.43,0.55,0.31,0.25,0.46,0.23,0.53,0.43,0.46,0.43,0.25,0.51,0.52,0.43,0.53,0.23,0.44,0.23,0.53,0.44,0.31,0.44,0.51,0.44,0.37,0.43,0.23,0.51,0.3,0.23,0.82,0.51,0.53,0.53,0.25,0.44,0.37,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.52,0.44,0.37,0.31,0.37" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">latter two concerns, we recently developed a database of modular antibody parts</text>
   <text y="703.602" x="438.841,441.643" svgx:width="0.48,0.48" style="fill:rgb(0,0,255);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">34</text>
   <text y="706.662" x="444.445,446.173,450.034,454.912,459.655,461.383,465.244,470.158,471.886,475.873,478.033,480.715,484.531,487.915,492.802,496.573,499.354,501.694,505.78,509.596,511.324,516.067,519.883,523.177,525.58,529.827,534.741,536.469,540.456,542.724,546.855,551.436" svgx:width="0.23,0.44,0.55,0.53,0.23,0.44,0.55,0.23,0.44,0.25,0.31,0.43,0.37,0.55,0.44,0.31,0.27,0.46,0.43,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.23,0.44,0.25,0.47,0.51,0.36" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;"> and an alternative design algo-</text>
   <text y="716.661" x="155.635,159.028,161.332,164.131,168.937,176.308,178.36,180.196,186.964,191.581,194.326,202.345,207.691,214.018,219.13" svgx:width="0.37,0.27,0.31,0.53,0.82,0.23,0.23,0.75,0.52,0.31,0.89,0.69,0.7,0.57,0.55" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">rithm, OptMAVEn</text>
   <text y="713.602" x="224.058,226.866" svgx:width="0.48,0.48" style="fill:rgb(0,0,255);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">35</text>
   <text y="716.662" x="229.674,231.51,234.093,238.575,241.914" svgx:width="0.23,0.3,0.51,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;"> for </text>
   <text y="716.662" x="243.75,248.286,251.886,253.74,258.465,262.578,266.565" svgx:width="0.51,0.4,0.23,0.53,0.47,0.45,0.47" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:9.0px;stroke:none;">de novo</text>
   <text y="716.662" x="270.804,272.64,277.392,281.217,284.52,286.932,291.188,296.111,297.947,302.429,305.093,306.929,310.736,315.218,322.418,327.071,329.348,333.173,335.863,339.688,341.524,343.801,346.213,350.488,355.123,357.868,359.704,363.574,368.462,373.214,375.05,379.819,383.698,387.487,391.762,395.893,397.729,401.896,405.766,409.159,411.598,415.477,419.986,422.263,426.088,427.924,432.676,437.159,444.502,448.372,450.784,455.635,458.938" svgx:width="0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.23,0.51,0.3,0.23,0.42,0.51,0.82,0.52,0.25,0.43,0.31,0.43,0.23,0.25,0.27,0.47,0.53,0.31,0.23,0.44,0.55,0.53,0.23,0.53,0.43,0.44,0.46,0.46,0.23,0.46,0.44,0.37,0.27,0.44,0.51,0.25,0.43,0.23,0.53,0.51,0.82,0.44,0.27,0.55,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;"> design of complete light and heavy variable domains.</text>
   <text y="726.661" x="167.646,173.817,178.547,181.316,183.671,188.302,192.952,197.686,200.08,203.887,207.172,208.891,212.74,215.94,219.747,221.462,224.24,228.989,232.796,234.515,236.774,240.631,244.564,249.298,251.692,256.522,260.716,262.435,266.166,268.448,272.352,275.588,278.873,280.592,285.053,287.699,289.418,292.196,296.945,300.752,304.073,307.832,312.608,316.415,321.065,323.833,326.227,330.016,333.301,335.335,337.054,341.677,346.438,350.245,351.964,354.358,359.263,360.982,363.264,367.113,370.358,374.477,378.284,380.003,384.743,388.592,392.0,394.727,396.446,399.116,403.688,405.407,408.184,412.934,416.741,419.135,422.456,424.175,428.033,432.475,434.911,437.17,439.452,442.202,446.315,448.034,450.704,455.276,456.995,459.389,464.119,466.789,470.596,473.917,477.85,481.699,484.426,486.145,492.315,494.599,497.376,502.164,503.883,508.617,510.981,514.218,516.987,519.381,524.247,528.096,530.823,532.542,534.801,537.195,541.389,545.237,550.103,554.855" svgx:width="0.69,0.55,0.31,0.27,0.51,0.51,0.53,0.27,0.43,0.37,0.23,0.44,0.37,0.43,0.23,0.31,0.53,0.43,0.23,0.25,0.43,0.44,0.53,0.27,0.55,0.47,0.23,0.42,0.25,0.44,0.37,0.37,0.23,0.51,0.3,0.23,0.31,0.53,0.43,0.37,0.44,0.52,0.43,0.53,0.31,0.27,0.42,0.37,0.23,0.23,0.53,0.53,0.43,0.23,0.27,0.55,0.23,0.25,0.44,0.37,0.47,0.43,0.23,0.52,0.44,0.37,0.31,0.23,0.31,0.51,0.23,0.31,0.53,0.43,0.27,0.37,0.23,0.44,0.51,0.27,0.25,0.27,0.31,0.46,0.23,0.31,0.51,0.23,0.27,0.55,0.31,0.43,0.37,0.44,0.42,0.31,0.23,0.69,0.27,0.31,0.53,0.23,0.53,0.27,0.37,0.31,0.27,0.55,0.42,0.31,0.23,0.25,0.27,0.47,0.44,0.55,0.53,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">Antibodies are the leading class of therapeutics, due in large part to their ability to interact with distinct ligand </text>
   <text y="736.66" x="155.649,159.519,164.064,169.05,171.696,176.242,179.698,187.105,190.949,193.802,196.277,200.823,205.737,209.103,211.164,213.639,218.625,220.686,225.231,228.517,233.332,237.22,240.622,242.683,245.438,250.091,252.152,256.004,258.344,260.819,264.689,267.056,269.864,271.925,276.75,280.684,284.176,287.03,289.505,293.438,298.326,300.693,304.627,308.029,310.09,314.617,317.092,321.683,324.023,328.676,332.997,335.472,339.37,343.429,345.769,347.83,351.116,355.004,358.326,363.186,367.732,372.647,376.085,379.973,383.339,385.454,387.515,394.248,398.757,404.914,408.875,413.033,416.921,419.756,421.871,423.932,428.747,431.195,434.633,438.503,443.012,447.171,451.059,454.722,458.916,460.977,465.523,468.25,470.311,475.261,479.222,485.45,487.511,494.909,499.5,501.84,505.773,509.706,514.594,516.934,520.822,524.188,526.249,530.776,533.251,538.202,543.017,545.492,550.406,554.618" svgx:width="0.42,0.51,0.55,0.3,0.51,0.37,0.82,0.44,0.31,0.27,0.51,0.55,0.37,0.23,0.27,0.55,0.23,0.51,0.37,0.53,0.43,0.37,0.23,0.31,0.51,0.23,0.43,0.25,0.27,0.42,0.27,0.31,0.23,0.52,0.44,0.37,0.31,0.27,0.42,0.53,0.25,0.44,0.37,0.23,0.51,0.27,0.51,0.25,0.51,0.47,0.27,0.42,0.44,0.25,0.23,0.37,0.43,0.37,0.52,0.51,0.55,0.37,0.43,0.37,0.23,0.23,0.77,0.51,0.69,0.43,0.46,0.43,0.37,0.23,0.23,0.53,0.27,0.37,0.42,0.51,0.46,0.43,0.37,0.46,0.23,0.51,0.3,0.23,0.55,0.43,0.69,0.23,0.82,0.51,0.25,0.43,0.42,0.53,0.25,0.43,0.37,0.23,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">conformations in order to elicit particular biological responses. However, discovery of new molecules binding </text>
  </g>
 </g>
</svg>
